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ABSTRACT 
Samuel T. Savitz: Health Literacy in Treatment Assignment and Medication Adherence: Application to 
Stable Angina Pectoris 
(Under the direction of Sally C. Stearns) 
Health literacy is a major determinant of health outcomes, spending, and hospital admissions. 
However, gaps in the literature remain on the relationship between health literacy and health behaviors. 
The objective of this dissertation was to assess the relationship between health literacy and key health 
behaviors for patients with stable angina pectoris. The dissertation had three aims: 1) evaluate the 
relationship between health literacy and treatment assignment: medication only, percutaneous coronary 
intervention (PCI), or coronary artery bypass grafting (CABG) surgery; 2) assess patient and clinician 
behavior during treatment planning conversations; and 3) evaluate the relationship between health literacy 
and adherence to anti-anginal medications for stable angina.  
We used a 20 percent Medicare claims sample from 2007-2013 to evaluate the first and third 
aims. Health literacy was assessed using an area-based measure. Multinomial logistic regression was used 
to evaluate the relationship between health literacy and treatment assignment. Probit regression, inverse 
probability of treatment weighting, and two-stage residual inclusion were used to assess the relationship 
between health literacy and medication adherence. For the second aim, we used recorded patient-clinician 
encounters and questionnaire data from the PCI Choice Trial. In this data source, health literacy was 
assessed using a validated screening question.  
Patients living in low health literacy areas had significantly higher utilization of medication only 
(3.3 percentage points) and lower utilization of CABG (-3.0 percentage points) compared to patients in 
high health literacy areas. This finding may be related to health literacy being a predictor of worse access 
to care. Low literacy was associated with greater decisional conflict among patients and may be a barrier 
in communication. The clinician and the setting in which the conversation took place may also be 
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important determinants of communication quality. Low health literacy may act as barrier to patient-
clinician communication. Living in low health literacy areas was also associated with significantly lower 
medication adherence when using the quartile specification of health literacy (-2.8 percentage points), but 
not the dichotomous specification. There was also strong evidence for selection into treatment 
assignment. The small magnitude of these findings do not support the use of health literacy to inform 
interventions to improve medication adherence. 
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CHAPTER 1. INTRODUCTION 
1.1. Specific Aims 
 About a quarter of all Americans have poor health literacy.1 This number is expected to grow in 
the coming years due to increases in the share and absolute numbers of elderly and individuals who speak 
English as a second language.2 Poor health literacy is associated with worse access to care, quality of 
care, and health outcomes. The associations between health literacy and these outcomes have been 
documented for a wide array of conditions.3 However, the existing literature does not adequately address 
the causal pathways of health literacy with treatment assignment and important patient behaviors such as 
medication adherence. Few studies have explored health literacy’s impact on treatment assignment; the 
existing studies have been small and used non-generalizable populations.4 Further, prior studies on the 
relationship between health literacy and medication adherence show mixed results.3 Patient 
comprehension of treatment options and effectiveness will become even more important as medicine 
transitions towards patient-centered care and shared decision-making. 
 The treatment of stable angina pectoris (SAP) is a promising area for evaluating the association of 
health literacy with treatment assignment (i.e., treatment choice) and medication adherence. SAP is a 
common condition with over eight million cases in the US.5 The high prevalence of stable angina means 
that the condition imposes a large public health burden. Treatment assignment (i.e., the treatment 
alternative that the patient receives after discussing treatment with their clinicians) depends heavily on 
patient preferences in addition to clinical presentation.6 The most commonly used treatments for SAP are 
medical therapy (i.e. medications alone), percutaneous coronary intervention (PCI) with medical therapy, 
and coronary artery bypass grafting (CABG) surgery with medical therapy.6 Medical therapy is the same 
for all groups and consists of beta-blockers, calcium channel blockers, long-acting nitrates, short-acting 
nitrates, and ranolazine.6 The alternatives vary in terms of cost,7,8 potential symptomatic benefit,9-12 and 
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type and risk of complications.13,14 Patients with poor health literacy may find it more difficult to weigh 
the risks and benefits of alternative treatments and to make an informed choice. Many of the risk factors 
associated with SAP (advanced age,15 lower socioeconomic status,16 and minority status5) are also 
associated with lower health literacy.1,17 Two prior studies analyzed how poor comprehension of the 
advantages and disadvantages of treatment alternatives affects treatment selection for SAP.18,19 The 
studies found that many patients who received PCI erroneously believed that the procedure would 
decrease their risk of death or myocardial infarction (MI) relative to medication therapy alone. This 
finding suggests that current patient-physician interactions are not resulting in informed decision 
making.19 For medication adherence, no identified studies have assessed health literacy and medication 
adherence among patients with SAP. Nevertheless, medication is a key component of treatment for all 
treatment alternatives including PCI and CABG.6 
 The long-term goal of this research is to improve our understanding of how health literacy patient 
treatment for chronic conditions , particularly as it relates to treatment assignment and adherence. The 
objective of this study is to evaluate the association of health literacy with treatment assignment and 
medication adherence among Medicare patients with SAP. The central hypothesis is that living in a low 
health literacy area (as measured by a validated area-based measure17,20) will be associated with a higher 
probability of receiving more invasive treatment (PCI or CABG) and lower medication adherence. This 
research will enhance our understanding of how health literacy acts as a barrier to informed decision-
making and improve patient adherence with assigned treatments.  
 Aim 1: Evaluate the association between an area-based measure for health literacy and 
assignment to more or less invasive treatment (i.e., medical therapy vs. PCI and CABG) for SAP. 
Hypothesis: Living in areas with low health literacy is associated with assignment of PCI and CABG over 
medication only. The analysis used multinomial logistic regression to analyze the relationship between 
treatment assignment and the health literacy measure using a 20 percent sample of Medicare claims data.   
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Aim 2: Evaluate clinician-patient interactions during treatment planning discussions for 
SAP. Hypothesis: The analysis evaluates potential barriers to effective clinician-patient communication 
including low health literacy and identify potential limitations in the claims data for Aim 1. The analysis 
used previously collected data from the PCI Choice Trial including audio and video recordings of 
clinician-patient encounters and patient questionnaires.   
Aim 3: Evaluate the association of area-based health literacy with post-treatment 
medication adherence. Hypothesis: Living in areas with low health literacy is associated with worse 
medication adherence. Medication adherence is assessed as the proportion days covered for any of the 
following medications: beta-blockers, calcium channel blockers, long-acting nitrates, and ranolazine. The 
relationship with the health literacy measure was assessed using probit regression, inverse propensity 
score treatment weighting (IPTW), and two-stage residual inclusion.  
 The findings from this mixed-methods study on treatment assignment and health literacy supports 
interventions to improve patient comprehension and shared decision-making; similarly, results on patient 
adherence to medications informs interventions to improve medication adherence by identifying the role 
of health literacy.  
1.2. Background 
1.2.1. Overview of Stable Angina Pectoris 
 Angina is a symptom of coronary artery disease that involves pain or discomfort in the chest area. 
Coronary artery disease is caused by a buildup of plaque in coronary arteries. The plaque narrows and 
stiffens the arteries, which reduces the supply of blood to the heart and causes the angina symptoms. 
Angina is classified as ‘stable’ if the symptoms exhibit consistent patterns in terms of how long they last 
and when they occur.21 Patients most commonly experience symptoms of SAP during physical exercise 
when the demand for blood is higher.21 The risk factors for developing SAP include advanced age, high 
cholesterol, high blood pressure, smoking, being overweight or obese, lack of physical exercise, and poor 
diet.21-23 SAP affects approximately eight million individuals in the US.5  
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1.2.2. Treatment for Stable Angina Pectoris 
 Patients with SAP have three main treatment options. The first option is medical therapy (for 
clarity, this alternative will be referred to as ‘medication only’). Patients that receive medication only are 
prescribed anti-anginal medications, which include short-acting nitrates, long-acting nitrates, beta-
blockers, calcium channel blockers, and ranolazine. Short-acting nitrates are taken as needed and the 
other medications are taken daily. The anti-anginal medications primary function is to manage the 
symptoms of angina.6 If patients do not achieve sufficient reduction in their symptoms, then they may 
receive one of the other treatment alternatives.6 The second alternative is percutaneous coronary 
intervention (PCI) plus medication. PCI is a non-invasive procedure in which a catheter is inserted into 
the blocked artery (or arteries) and a balloon on the end of the catheter is expanded to push the plaque 
against the walls of the artery. Usually, a stent is then positioned in the artery to keep it from re-
narrowing. The stents are either bare metal stents (BMS) or drug-eluting stents (DES) that release a drug 
to prevent reblockage6,21 The third alternative is coronary artery bypass graft (CABG) surgery. CABG is 
an invasive surgery in which the chest is opened to access the blocked artery. Then, healthy arteries or 
veins from other parts of the body are grafted to bypass the blocked or narrowed coronary arteries.6,21 
Patients who receive PCI or CABG also receive the same anti-anginal medications that patients in the 
medication only group receive.6 
 In addition to the anti-anginal medications, patients in all three treatment alternatives receive 
other medications to reduce the risk of MI, stroke, and death.6  These medications include statins, ACE 
Inhibitors, antiplatelets, and anticoagulants.6 Dual antiplatelet therapy (aspirin and clopidogrel) is 
especially important for patients who receive PCI with a BMS or DES.14,24,25 For these patients, the dual 
antiplatelet therapy helps to prevent stent thrombosis,14,24,25 which is a complication where a blood clot 
occurs in the artery that has had the stent implanted. Stent thrombosis often results in MI and death.26 
Given the importance of dual antiplatelet therapy for PCI, physicians are guided to not perform PCI if 
they do not believe the patient is likely to be adherent to dual antiplatelet therapy following the 
procedure.6 
 5 
The treatment alternatives have key tradeoffs in terms of cost, symptom relief, and complications. 
Medication only is the least expensive alternative.7 Patients who receive medication only generally have 
similar outcomes in terms of MI and death as patients who receive PCI or CABG.27,28 However, these 
findings do not extend to the small subset of patients with left main disease who have often been excluded 
from trials.6,27,28 Long-term symptom relief for patients who receive medication only is comparable to 
patients who receive PCI.12 But, a greater proportion of patients who receive PCI experience short-term 
symptom relief than patients who receive medication only.12 The recent ORBITA trial found no statistical 
difference in exercise time at six weeks between PCI plus medications and a sham procedure plus 
medications.29 These findings raise the possibility that the difference in short-term relief may be partially 
due to a placebo effect from receiving a procedure. However, it is difficult to make definitive conclusions 
from this study because the population was relatively small and the main outcome (exercise time) was an 
intermediate outcome.29 PCI is more expensive than mediation only7 and less expensive than CABG.8 The 
main complications for PCI are stent thrombosis26 and restenosis, which is a reblockage of the artery that 
may require additional revascularization.30 CABG is the most expensive and most invasive alternative.8 
CABG also leads to more complete reduction of symptoms than PCI or medication only.9,11,31 CABG and 
PCI have similar outcomes for patients who have uncomplicated coronary artery disease. For patients 
with complex coronary artery disease, CABG reduces the risk of MI.10,11 In addition, CABG has better 
outcomes for patients with diabetes32,33 Due to the invasive nature of the procedure, CABG requires 
surgical recovery34 and rehabilitation.6 In contrast, patients who receive PCI typically have faster 
recovery35 and it is increasingly common for PCI to be performed as an outpatient procedure.36 
Prior research suggests that patients with SAP have difficulty understanding the tradeoffs 
between the treatment alternatives. A survey of patients after a treatment decision for SAP found that 
most patients who received PCI mistakenly believed that the PCI would reduce the risk of MI compared 
to medication only.19 As noted, PCI generally does not reduce the risk of MI or death for SAP patients.27 
A separate survey of the physicians treating these patients found that most  physicians correctly believed 
that the benefit of PCI relative to medication only would be limited to symptom relief.19 A related study 
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presented a hypothetical treatment scenario for SAP to individuals in the general community. Participants 
were randomized to one of three arms that varied by how patients were presented information on PCI and 
the risk of MI (no information, an explicit statement that PCI does not reduce the risk of my, or an 
explanation of why PCI does not reduce the risk of MI). Most individuals (71%) in the ‘no information’ 
arm believed that PCI reduced the risk of MI.18 A smaller share of patients in the ‘explicit statement’ arm 
(39%) and ‘explanation’ arm (31%) believed that PCI reduced the risk of MI.18 Individuals who believed 
PCI reduced the risk of MI were much more likely to opt for PCI.18 The results of these studies suggest 
that individuals have a strong tendency to believe that PCI will reduce the risk of MI and that there may 
be barriers to information exchange on this topic between physicians and patients. These barriers may be 
partially overcome by how the information is presented.  
1.2.3. Relationship of Health Literacy with Treatment Assignment and Medical Decision-Making 
 The prior literature on health literacy and treatment assignment is difficult to summarize due to 
inconsistencies in the studies. Specifically, a scoping review of the literature on health literacy and 
medical decision-making found that there was little overlap in the type of health literacy measure used 
(e.g., REALM37 or TOFHLA38),  the aspect of medical decision-making being evaluated, and the study 
populations.4 The review concluded that general statements about how health literacy relates to medical 
decision-making was not possible due these limitations.4  
 Several studies have examined the relationship of health literacy with preferences for 
participation in treatment decisions and the actual levels of participation. Prior research has found that 
patients with low health literacy were more likely to prefer more passive roles in treatment decisions.39,40 
But other research has found no significant differences in preferences for involvement by health literacy 
level.41 In terms of actual involvement, patients with low health literacy have been found to be less likely 
to ask questions during treatment planning discussions.41,42 The lower levels of involvement may be 
explained by patients with low health literacy experiencing greater difficulty understanding the 
information presented by the clinicians. Patients with low health literacy are more likely to give poor 
assessments for general clarity and the quality of explanations provided by clinicians.43 Clinicians were 
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also found to regularly use unclarified jargon terms in a population of low health literacy patients.44 
Therefore, patients with low health literacy may have similar degrees of involvement as other patients if 
clinicians tailor their explanations to the patient’s health literacy level. 
 Low health literacy has also been linked to a preference for more aggressive care. Several studies 
have found that patients with low health literacy prefer more aggressive care in the context of end-of-life 
treatment for dementia.45-47 These findings may suggest that patients with low health literacy may also 
prefer more aggressive care (CABG or PCI) for the treatment of (SAP). However, it is unclear how 
applicable these findings are since the decision for treatment of SAP is very different than the decision for 
end-of-life care for dementia. We were unable to identify any studies that evaluated the relationship 
between health literacy and treatment preferences for aggressive care with respect to cardiovascular 
disease.  
1.2.4. Relationship Between Health Literacy and Medication Adherence 
 The prior literature on the relationship between low health literacy and medication adherence has 
found mixed results. Three recent systematic reviews have examined this relationship.3,48,49 Two reviews 
found inconsistent evidence3,48 and one that included a meta-analysis found a small, significant 
association between low health literacy and worse medication adherence.49 Many of the studies in two of 
the reviews3,49 focused on medication adherence for HIV and these results may be less applicable to 
medication adherence for SAP. One of the systematic reviews focused on medication adherence for 
cardiovascular disease and diabetes48 and as such may be more applicable. Of the seven studies included 
in the systematic review,50-58 only one study found a significant association between low health literacy 
and worse medication adherence.56 Two additional studies found associations between low health literacy 
and worse adherence that were only significant in unadjusted comparisons.54,58 Recent studies that were 
published after this systematic review have continued to provide conflicting evidence: some have found a 
significant association for health literacy and medication adherence59,60 while others have not found a 
significant association.61,62 Overall, the conflicting findings make it difficult to make a definitive 
conclusion about the relationship between health literacy and medication adherence. All three systematic 
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reviews concluded that more evidence was necessary to evaluate this relationship.3,48,49 In particular, 
research is needed that addresses some of the methodological weaknesses of the existing studies, which 
include small sample sizes and populations that are difficult to generalize from.48   
1.3. Significance 
SAP is a promising area for research. The high prevalence of the condition (eight million patients 
in the US5) means SAP imposes a large public health burden. Patients with SAP appear to have confusion 
regarding treatment alternatives. Compelling evidence indicates that patients tend to believe—often 
mistakenly—that more invasive treatment with PCI reduces the risk of MI and mortality compared to 
medical therapy.19,63 Using cardiovascular disease medications as prescribed is strongly associated with 
better angina-related outcomes. However, medication non-adherence is still a common issue for 
cardiovascular drugs.64 Therefore, it is important to understand adherence patterns for these patients. 
Health literacy is a key factor that may affect both treatment assignment and medication 
adherence for SAP patients. Low health literacy may contribute to the confusion surrounding the 
treatment alternatives for SAP. Previous research suggests that health literacy may act as a barrier for 
patients making health-related decisions.39,65,66 However, these studies had small sample sizes and poor 
generalizability. Low health literacy may also be linked to worse medication adherence. Previous 
systematic reviews on health literacy and medication adherence found the evidence for such a relationship 
inconclusive but limited.3,48,49 The studies included in the reviews typically had small samples and limited 
generalizability because they are drawn from a single institution or region.48 Health literacy is an 
important factor to target since it is potentially modifiable or it can be targeted with interventions. Past 
research has shown that interventions that are sensitive to health literacy can improve health outcomes 
and reduce disparities by level of health literacy.67-71 In contrast, other factors associated with health are 
either fixed (e.g., age and sex) or are difficult to address with office-based interventions (e.g., socio-
economic status).  
 The proposed research is significant because it overcomes limitations found in past studies and 
informs potential interventions that are sensitive to health literacy. The analysis uses a 20 percent sample 
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of Medicare claims to generate a larger and more generalizable sample than in previous research. The 
results provide evidence on how area-based health literacy is related with treatment assignment and 
medication adherence. The descriptive analysis of the recorded patient-clinician encounters provides 
additional depth to the analysis. The findings help to inform interventions so they are suitable for patients 
with limited health literacy skills such as shared decision-making tools67 and medication reminders.71  
1.4. Innovation 
 This dissertation is innovative because it combines Medicare claims data and an area-based 
measure for health literacy. As noted earlier, samples for prior studies were typically drawn from single or 
few geographic sites.40-43,45-47,50-62 Therefore, external validity is a major concern. In addition, the sample 
sizes for most of these studies was also small (fewer than 500 individuals).40-43,45-47,50-53,55-62  Such studies 
were expensive to conduct in part because they required an in-person assessment of health literacy. 
Medicare data have been used to study medication adherence and treatment assignment outside of the 
health literacy literature,72-74 but analyses of health literacy have not included large claims analyses since 
health literacy measures are typically unavailable with claims data. The area-based measure for health 
literacy has only recently been developed and validated.20 The validation study also linked the area-based 
measure to Medicare claims data to analyze the relationship between community health literacy and 30-
day readmissions for patients with acute MI.20 The area-based health literacy measure has not yet been 
used to study treatment assignment or medication adherence in a claims database. There are also 
important limitations to using an area-based measure for health literacy. The limitations include the 
ecological fallacy and the high correlation between an area-based measure for health literacy and area-
based measures for low-income like the ADI.75 However, using an area-based measure is the only 
approach that would enable an analysis with a large claims database.  
 The dissertation research has the advantage of being more nationally representative and less 
costly than prospective studies. Although the study only focuses on SAP, it demonstrates that the same 
approach could be applied to other conditions with preference-sensitive treatments or chronic medication 
use. More generally, this research represents a novel combination an area-based measure with claims data 
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to answer research questions that cannot be answered with claims data alone and for which a prospective 
study is infeasible due to the sample size and resources required. 
1.5. Conceptual Models 
1.5.1. Conceptual Model for Aims 1 and 3 
The conceptual model for the analyses of the relationship between health literacy and treatment 
assignment (Aim 1) and health literacy and medication adherence (Aim 3) is  a modified version of the 
Andersen Behavioral Model.76 This model has been widely used to explain health behavior and utilization 
of health services in prior research.77 The model categorizes the major determinants of health behavior as: 
1) the environment in which the individual lives, 2) predisposing factors that are inherent individual 
characteristics, 3) enabling resources which determine individuals’ ability to afford and access care, and 
4) clinical need. The heavy red lines and arrows in Figure 1.1 identify the key relationships of interest for 
Aim 1 and Aim 3. The main agents who participate in treatment assignment are patients, caregivers, and 
physicians. For medication adherence, the main agents are the patients and caregivers. We do not consider 
physicians to have a large effect on medication adherence since they are unlikely to have much contact 
with the patient outside of medical visits, though some physicians may be better at encouraging adherence 
than others.  
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Figure 1.1. Modified Andersen Conceptual Model of Healthcare Utilization76 
 
Note: SES stands for socio-economic status 
 
Environment: The model describes how the environment can interact with patient characteristics 
to affect health behavior for SAP. The analyses considered physician/hospital supply as key 
characteristics of the health care system. Prior research suggests that low medical supply in a region is 
linked to worse outcomes.78 As such, the analyses controlled for the supply of primary care physicians, 
cardiologists, and hospital beds per 10,000 residents at the county level. The analyses also controlled for 
whether a county is rural, since rural areas tend to have lower medical supply than more urban areas.79 
Another key aspect of the external environment is the year in which the beneficiary receives care. Over 
the period of the study, there were new studies27 and clinical practice guidelines6 that may have affected 
how patients were treated. The year of diagnosis was included in models to account for any changes in 
clinical practice over time.   
Predisposing factors: The analyses focused on the predisposing factor of health literacy as the 
key independent variable. Specifically, the analyses used an area-based measure of health literacy to 
assess the relationship between community health literacy with treatment assignment and medication 
adherence. The methods sections for each analysis describes how the area-based health literacy measure 





































has been found to be significantly associated with health literacy.17 If SES were not included in the 
models, then SES would likely be a confounder for health literacy with respect to treatment assignment 
and medication adherence. As such, the analyses included the area-deprivation index as a control variable 
for SES.75 Race and ethnicity may also act as predisposing factors since minority status has been linked to 
lower quality of care.80 A control variable for race and ethnicity was also included in the models.  
Enabling resources: The main enabling resources are insurance status and caregiver support. For 
the analyses, all patients had Medicare fee-for-service coverage and there were no uninsured patients. The 
only differences in insurance status were that some low-income patients qualified as full dual eligible, 
partial dual eligibles, or recipients of the low-income subsidy for Part D. Full dual eligibles receive cost-
sharing reduction and premium support and partial dual-eligibles just receive premium support.36 Patients 
who receive the low-income subsidy have lower Part D premiums and lower cost-sharing for 
medications.36 The analyses included variables for the proportion of time that a patient was a full dual 
eligible, partial dual eligible, or received the low-income subsidy. Caregiver support could not be 
identified in the claims data.  
Need: The important clinical aspects that affect care for SAP include the number of arteries that 
are blocked, which arteries are blocked, the extent of the blockage, anatomic variants, symptom status, 
age, and important co-morbidites.6 Many of these characteristics were not available in the claims data. We 
were able to identify and exclude patients with unstable angina or previous MI. We were also able to 
identify co-morbidities. We controlled for general co-morbidities by using the Charlson co-morbidity 
index81 and separately included an indicator for diabetes, which is associated with treatment outcomes.10 
We also controlled for the age of the patient.   
1.5.2. Conceptual Model for Aim 2 
 The conceptual model for the Aim 2 analysis of recorded patient-clinician encounters for SAP is 
a modified version of the interprofessional shared-decision-making model.82 The model was designed to 
represent shared-decision making between a patient, health care professionals, and family members. 
Given that average shared decision-making levels are low for many medical decisions,83 this model may 
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not reflect well what actually occurs for many encounters. Nevertheless, the model is helpful for 
observing how well actual conversations conform to it. The key elements include the environment in 
which the medical decision is being made and the family/patient and professional teams working together 
to make the health decision. The teams work together through five steps that lead to a treatment decision. 
The two-way arrows between the steps indicate that it is possible to revisit earlier steps at a later point.  
Figure 1.2. Modified Version of the Inter-professional Shared Decision-making Model82 
 
 
 Environment: The environment in which the discussions take place affects the subsequent steps 
and the individuals that are involved in the teams. For the Aim 2 analysis, the recording took place at the 
general cardiology clinic or cardiac catheterization lab at the Mayo Clinic in Rochester, MN. The 
encounters may have been affected by taking place at the Mayo Clinic, which is a premier health system 
that may have different approaches to patient-clinician interactions than most health systems. The 
conversations may have also been affected by whether they took place at the general cardiology clinic or 
cardiac catheterization lab. Patients seen at the cardiac catheterization lab may be much more likely to 
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receive PCI than patients seen at the general cardiology clinic since the catheterization lab is where PCI is 
performed.  
 Teams: The two teams are the patient/family team and the interprofessioanl team. The 
patient/family team includes the patient, family members, significant others, or other surrogates. In the 
analysis of recordings, we identified whether the patient had a family member or caregiver present during 
the encounter. Prior research suggests that family members and caregivers can help support patients with 
low health literacy.84  The interprofesional team includes physicians, nurses, and other health providers.  
 Steps in treatment selection: The five steps for treatment selection inform the outcomes used in 
the Aim 2 analysis. The quality of information exchange was assessed in three different ways. First, the 
OPTION12 instrument was used to assess the shared decision-making behavior of the interprofessional 
team.85 This outcome measures how the interprofessional team interacts with patient team in the 
information exchange step. Second, patient understanding of information presented in the information 
exchange step was assessed using knowledge questions about the treatment alternatives for SAP. Patients 
completed these questions immediately following the encounter.63 Third, we assessed the question asking 
behavior of patients during the encounters. This outcome measured the interaction between the patient 
and interprofessional team. The values/preferences step was assessed by counting the frequency of 
patients expressing preferences for treatment during the encounters. The preferred choice step was 
assessed using the Decisional Conflict Scale (DCS).86 The DCS measures whether patients feel they have 
the information needed to express treatment preferences and how uncertain they are. The decision to be 
made and feasibility steps were not directly assessed, but some of the outcome measures touch upon these 
aspects of the treatment selection process. More detailed information on the study measures can be found 
in the Chapter three methods section.  
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CHAPTER 2. TREATMENT ASSIGNMENT FOR STABLE ANGINA PECTORIS: THE 
ROLE OF HEALTH LITERACY 
2.1. Overview 
Background: Prior research suggests that patients with stable angina pectoris (SAP) have 
difficulty understanding tradeoffs between treatment alternatives. More invasive treatment has not been 
associated with better clinical outcomes (e.g., myocardial infarction or death), however, many patients 
believe that more invasive treatment reduces the risks of these outcomes. Patients living in communities 
with lower average health literacy may be more likely to have misconceptions and receive more invasive 
treatment.  
Methods: Analysis of fee-for-service (FFS) Medicare beneficiaries (20% random sample). The 
sample included beneficiaries with an incident diagnosis of SAP in 2007-2013. The treatment alternatives 
were: 1) medication only, 2) percutaneous coronary intervention (PCI), and 3) coronary artery bypass 
grafting (CABG) surgery. The key independent variable was an area-based health literacy measure at the 
census block group level derived from a validated predictive model. This variable was specified as a 
dichotomous measure (low vs. high). The relationship between treatment and health literacy was 
evaluated using multinomial logistic regression, controlling for socio-demographic and case mix 
measures.  
Results: The study sample included 15,435 patients. Patients living in communities with low 
health literacy (n=1,631) were significantly more likely to receive medication only (3.3 percentage points 
more likely for low vs. high health literacy) and less likely to receive CABG (-3.0 percentage points more 
likely). The magnitude of the marginal effects decreased after adding an Area Deprivation Index (ADI) to 
the model to control for area-based socioeconomic status.    
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Conclusions: Living in communities with lower average health literacy was associated with 
lower utilization of invasive treatment (PCI or CABG) and higher use of medication only. Treatment 
assignment may be driven by other factors such as physician assessments or access to care.  
2.2. Introduction 
 About 80 million people, a quarter of all Americans, have poor health literacy.1 Low health 
literacy is associated with worse access to care, poorer quality of care, and negative health outcomes for a 
wide array of conditions.2 Health literacy may also impact patient’s ability to understand treatment 
alternatives and to participate in treatment decisions.3 Patient comprehension of treatment options will 
become even more important as medicine transitions towards patient-centered care and shared decision-
making.  
The treatment of stable angina pectoris (SAP) is a promising area for evaluating the impact of 
health literacy on treatment decisions. Treatment depends in part on patient preferences,4 so patients’ 
ability to understand the tradeoffs between treatment options may influence the care they receive. The 
most commonly used treatments for SAP are medication only (treatment with prescription medications), 
percutaneous coronary intervention (PCI) with medication, and coronary artery bypass grafting (CABG) 
with medication. The alternatives vary in terms of cost, how long it takes to receive symptom relief, and 
type and risk of complications.  
Medication only is the least expensive alternative and has comparable long-term symptom relief 
relative to PCI in patients with SAP.4,5 However, a greater share of patients experiences short-term 
symptom relief from PCI than medication only.5 PCI is more costly6 and more invasive than medication 
only and requires adherence to dual antiplatelet therapy to prevent stent thrombosis.7 CABG results in 
more complete symptom reduction than the other alternatives.8-10 But CABG is also the most invasive 
(with time needed for surgical recovery),11 most costly,12 and has a small risk of death or other serious 
complications.13  Outcomes for CABG relative to PCI are similar for patients who have more limited or 
uncomplicated coronary artery disease. However, for patients with more complex coronary artery disease, 
there appear to be improvements in major adverse cardiac and cerebrovascular events.9,14  
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The purpose of this analysis was to examine the relationship between health literacy and 
treatment assignment for SAP among Medicare beneficiaries. Such analyses have historically been 
difficult to conduct, as measuring literacy skills on an individual-level is logistically difficult and 
generally involves conducting in-person assessments; this is not plausible for large study samples. 
Recently, a predictive model of health literacy, which utilizes data from the US census to estimate the 
average health literacy skills of individuals living in a census block group, was published and 
validated.15,16 Such a model allows for investigations of the relationship between health literacy and SAP 
treatment assignment on an unprecedented level. To assess this potential relationship, the analysis used 
claims for a 20 percent sample of Medicare beneficiaries. We examined the treatment that patients 
received (medication only, PCI, or CABG) and evaluated the association with the area-based health 
literacy measure while controlling for other factors.  
2.3. Methods 
2.3.1. Data Sources 
The main data source was claims for a 20 percent random sample of Medicare for beneficiaries 
aged 65 and older who had at least one month of simultaneous coverage in fee-for-service Parts A 
(hospital), B (outpatient medical), and D (prescription drug) insurance from 2007-2014. Parts A and B 
claims from 2006 were used to exclude patients with SAP prior to 2007 from the sample. The claims data 
were supplemented with: 1) the Area Health Resource File (AHRF), 2) health literacy estimates at the 
census block group level,15,17 and 3) an area deprivation index at the 9-digit ZIP Code level.18 The AHRF 
is a database with variables on regional medical supply, socioeconomic status, and health status.19  This 
research was approved by the Institutional Review Board at the University of North Carolina at Chapel 
Hill.   
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2.3.2. Sample Selection 
Figure 2.1. details the steps in the sample selection process. The steps were designed to select 
patients with incident diagnoses of SAP on inpatient or outpatient claims who were eligible to receive 
medication only treatment. Appendix Tables 1-3 provide additional information on the specific codes 
used in this analysis. 
2.3.3. Variable Selection 
The dependent variable was a categorical variable for the treatment received: medication only, 
PCI, and CABG. Patients were categorized as PCI or CABG if they had the treatment within one year of 
the index date. If patients received both PCI and CABG within the first year, then the patients were 
assigned based on which treatment occurred first. Patients were categorized as medication only if they 
had at least one claim for a nitrate and no claims for PCI or CABG within one year of the index date (i.e., 
date of first claim with a diagnosis of SAP after January 2007). 
The key independent variable was health literacy. The analysis used an area-based measure for 
health literacy. The health literacy measure was estimated using a predictive model developed from the 
2003 National Assessment of Adult Literacy (NAAL).15,16 The predictive model included measures for 
gender, age, race/ethnicity, education, income, marital status, language spoken at home, rurality, and time 
in the US.15 For this study, the demographic measures were derived from the 2010 US Census.17 The 
predicted health literacy scores range from 0-500 and are sorted into four NAAL designations: below 
basic (0-184), basic (185-225), intermediate (226-309), and proficient (310-500). These NAAL 
designations are based on what skills patients in those categories are able to perform.1 The use of the 
predictive model for health literacy has been validated in prior research.15,17 The variable was 
operationalized in this study using both a dichotomous measure as well as quartiles based on the national 
distribution of scores at the census block group level. Previous studies used a dichotomous categorization 
of “Above Basic” or “Basic/Below Basic” based on NAAL categories to operationalize this variable.15,17 
For clarity, “Above Basic” will be referred to as “high health literacy” and “Basic/Below Basic” will be 
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referred to as “low health literacy.” The quartile specification was also used because it allowed for a more 
detailed assessment of the pattern of association of health literacy with treatment assignment.   
The individual-level variables were limited to the information available in the claims data. The 
patient-level control variables included race/ethnicity (white, black, hispanic, and other),20 age, sex, the 
Deyo version of the Charlson comorbidity index,21 and indicators for diabetes. Diabetes was included 
separately from the Charlson comorbidity index because CABG may be more beneficial for patients with 
diabetes.22 The analysis also included county-level measures of primary care physicians, cardiologists, 
and hospital beds per 10,000 residents to control for regional medical supply. Year and state fixed effects 
controlled for time trends and time-invariant state-specific characteristics.  
In our primary analysis, variables for rural status, area deprivation index (ADI),18,23 and the 
proportion of patients receiving CABG or PCI from physicians in the service area (defined as the Hospital 
Referral Region) were excluded because they were expected to be highly correlated with the health 
literacy variable. The ADI is a neighborhood-level measure for socioeconomic status. The ADI for this 
analysis was derived from 2000 Census data and it incorporated variables including education, income, 
employment, and housing.18,23 The predictive model used to create the health literacy variable also 
included area-based measures for rurality and income.15 We included these variables in alternative 
specifications to assess the robustness of our findings. Rural status was calculated at the county level and 
was derived from the AHRF. The ADI was merged at the nine-digit ZIP code level. The ADI variable was 
specified as a dichotomous variable24 and as quartiles of the ADI based on national data. The 
dichotomous measure for ADI was used in the models with the dichotomous measure for health literacy 
and the quartile version of ADI was used in the models with the quartile measure for health literacy.  
The proportion of patients receiving CABG or PCI were two area-based time-varying measures at 
the Hospital Referral Region (HRR) level. These two variables were calculated as three year moving 
averages to ensure a sufficient number of observations for each HRR and also to allow for changing 
trends over time. To calculate the proportions, all patients that met the sampling criteria were included 
except the patient for whom the calculation was made. The reason for this exclusion was so that the 
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proportion receiving PCI or CABG was not affected by the patient’s own treatment status. HRR fixed 
effects to control for time-invariant HRR characteristics were considered but ultimately not included 
given the large number of HRRs.    
2.3.4. Statistical Methods 
Multinomial logistic regression models were used to assess the relationship between health 
literacy and treatment assignment. The dependent variable was a three-category variable: Medication 
only, PCI, and CABG. The results are presented using the average marginal effects for each variable. The 
independence of irrelevant alternatives (IIA) assumption was tested using the Hausman-McFadden test25 
to assess the regression coefficients. The results of the test were dependent on which outcome was 
omitted from the analysis. When medication only was omitted, the test statistic was non-significant 
(p=0.95). However, when PCI was omitted, the test statistic was significant (p<0.01). For this analysis, 
the multinomial logit models were maintained as the main specification.  
Five models were estimated for the main analysis. The first model was a bivariate regression of 
treatment received on health literacy. The second model included the basic controls, excluding area-level 
variables that were expected to be correlated with health literacy. The third model added both rural status 
and ADI. The fourth model added the two HRR treatment measures. The fifth model included rural status, 
ADI, and the two area-based treatment measures. The five models were separately run once using the 
health literacy dichotomous measure and another time using the health literacy quartiles.  
2.3.5. Sensitivity Analysis 
 To assess the IIA violation, the relationship was re-estimated with treatment collapsed as a two-
category variable. The categories were procedures (CABG or PCI) and medication only.  
2.4. Results 
2.4.1. Descriptive Statistics 
 Descriptive statistics for the sample of 15,435 beneficiaries are provided by the two-levels of the 
dichotomous health literacy measure and overall in Table 2.1. Patients living in areas with low health 
literacy were slightly younger, more likely to be male, and more likely to be a racial or ethnic minority. 
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Living in areas with low health literacy was also associated with a higher probability of being low-income 
(full or partial dual eligible or LIS) or being in worse health (diabetes and slightly higher Charlson 
Comorbidity scores). About half of beneficiaries living in low health literacy areas also lived in areas with 
high ADI. The correlation coefficient between the health literacy measure and ADI variables was 0.31, 
which indicates a moderate degree of correlation between these area-based measures. The greatest shares 
of observations occur in the earliest years. Descriptive statistics stratified by the quartile measure of 
health literacy are presented in Appendix Table 4. The quartile results were largely consistent with the 
dichotomous statistics in that living in low health literacy areas tended to be associated with a higher 
proportion of racial/ethnic minority residents, being in worse health, and having lower median census-
tract income.  
2.4.2. Regression Results 
 We focus on regression results for the dichotomous measure of health literacy (Table 2.2.); results 
for the quartile measure are available in an online appendix. Before adjustment, patients living in the low 
health literacy areas were more likely to receive medication only (11.9 percentage points) and less likely 
to receive CABG (-6.1 percentage points) or PCI (-5.8 percentage points) as compared with patients 
living in high health literacy areas. After adding controls, the effect was reduced for medication only (3.3 
percentage points difference between the low and high groups) and CABG (-3.0 percentage points), 
though both were still statistically significant. Higher deprivation, rural status, dual enrollment in 
Medicaid, receiving a low-income subsidy, and black race were associated with being more likely to 
receive medication only and less likely to receive either CABG or PCI. Using the quartile specification of 
health literacy with adjustment for covariates (Appendix Table 5), medication only and PCI use remained 
statistically significantly lower among patients living in the lowest health literacy quartile versus the 
highest quartile, while CABG became non-significant.  
 Adding ADI, rural status, and treatment area-based measures reduced the magnitude of the 
marginal effects of the health literacy measure in the dichotomous specification (the last two columns). 
The decrease in magnitude was much larger when adding rural status and ADI compared to the treatment 
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area-based measures. The marginal effect for CABG by health literacy level remain significant when 
compared to the highest level for all models. Figures 2.2. (dichotomous) and 2.3. (quartile) show the 
results in terms of the predicted percentage of patients receiving each treatment alternative in the final 
model that controls for ADI, rural status, and treatment area-based measures. Figure 2.3 shows that, for 
the quartile specification, there is a consistent pattern across the quartiles. For example, the first quartile 
has the highest use of medication only, the fourth quartile has the lowest use of medication only, and the 
two middle quartiles have levels of use in between the first and fourth quartile.     
2.4.3. Sensitivity Analysis 
 The sensitivity analysis from the logit model for receiving either invasive procedure (PCI or 
CABG) versus medication only yielded results that were largely consistent with the main specifications 
(Appendix Tables 8 and 9). Living in a low health literacy area (both dichotomous and quartile 
specifications) was associated with being less likely to receive either CABG or PCI. After adding ADI 
and rural status to the models, the dichotomous specification was no longer significant and only the 
marginal effect for the lowest quartile was still statistically significant.  
2.5. Discussion 
2.5.1. Summary of Findings 
 This analysis provided a novel assessment of the relationship between health literacy and 
treatment assignment for patients with SAP. Patients living in communities with lower average health 
literacy were more likely to receive medication only. For CABG, the opposite was true: patients living in 
areas with lower average health literacy were significantly less likely to receive CABG. After adding 
controls for ADI, rural status, and an area-based measure of patients receiving PCI and CABG, the 
magnitude of the marginal effects became smaller, but many remained significant. These findings suggest 
that while some of the association between these variables may be explained other factors such as 
socioeconomic status, an association between health literacy and treatment received remains even after 
controlling for other potential explanations, including ADI.   
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 To our knowledge, this study was the first to assess the relationship between health literacy and 
treatment assignment using claims data and an area-based measure for health literacy. Previous literature 
examining treatment assignment for SAP showed that patients tended to believe that PCI would reduce 
the risk of death and myocardial infarction, and that this belief may have influenced the treatment they 
received.26,27 Several studies found that patients with low health literacy tend to prefer more aggressive 
treatment for end-of-life care.28-30  
Two prior studies analyzed how poor comprehension of the advantages and disadvantages of 
treatment alternatives affects treatment assignment for SAP.26,27 The studies found that many patients who 
received PCI erroneously believed that the procedure would decrease their risk of death or myocardial 
infarction relative to medication only alone. This finding suggests that current patient-physician 
interactions are not resulting in patients being informed about the treatment alternatives.26,27 One possible 
explanation for continued high rates of invasive treatment (especially PCI) is that patients with low health 
literacy may find it more difficult to weigh the risks and benefits of treatment alternatives and to make an 
informed treatment decision.31,32 Many of the risk factors associated with SAP (advanced age,33 lower 
socioeconomic status,34 and minority status35) are also associated with lower health literacy.15  Another 
potential explanation is that there are community factors that contribute to misconceptions and higher 
utilization of PCI. For example, communities with lower average health literacy may be more likely to 
have misconceptions about treatment spread among neighbors and have fewer resources to correct these 
misconceptions.  
2.5.2. Possible Mechanisms 
The average health literacy skills of one’s community could potentially affect treatment 
assignment in several ways. First, patients living in communities with lower average health literacy may 
have greater difficulty understanding the risks and benefits of treatment options.26,27 Second, clinicians 
may discourage patients who they perceive as having low health literacy from receiving PCI because of 
concerns about these patients not being adherent to dual antiplatelet therapy. Patients who receive PCI 
must also maintain adherence to dual antiplatelet therapy to avoid complications.7 Third, patients with 
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low health literacy may have higher distrust of physicians36 and a result be more reluctant to receive PCI 
or CABG than patients with high health literacy. Fourth, there may be regional patterns in health care 
system policies or provider beliefs that affect whether patients receive PCI and CABG and are also 
correlated with area-based health literacy Fifth, patients living in communities with lower average health 
literacy may also have worse access to care, which may make it more difficult for these patients to receive 
CABG or PCI. Prior research has found that patients with low health literacy have worse access to care.37-
39 
In total, the results showed that patients with low health literacy were more likely to receive the 
non-surgical treatment alternative (medication only) and less likely to receive PCI. The models included 
controls for other characteristics associated with poor access to care: rural status,40 variables related to 
low-income41 including ADI, full or partial dual eligibility, and the LIS; and racial/ethnic minorities.42 
The marginal effects for health literacy were also in the same direction as these established predictors for 
poor access. Therefore, it is possible that low area-based health literacy is an independent predictor for 
worse access to care. Previous research on health literacy and access to care has been inconsistent with 
some studies suggesting health literacy is a predictor for having worse access to care,37-39 while others did 
not.39,43  
This study provides evidence that low area-based health literacy may act as a barrier to receiving 
invasive treatment of SAP. However, this barrier may actually benefit patients if PCI is overused. The 
2007 COURAGE trial found no significant difference in the risk of death or myocardial infarction for 
SAP patients without left main coronary artery disease who received medication only compared to PCI 
and medication only.44 While the rates of PCI decreased following publication of findings from 
COURAGE, the decrease was lower than expected.31,32 The smaller than expected impact may mean that 
the use of medication only remains lower than would be optimal given the lower cost and risks involved 
with PCI and CABG. The recent ORBITA trial results also provided evidence that there was not 
significant improvement in exercise time for patients that received PCI plus medication relative to 
patients that received a sham procedure plus medication. However, the ORBITA results are controversial 
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because of the small sample size and use of a surrogate outcome (exercise time instead of symptom 
relief).45  
2.5.3. Limitations 
 This analysis has several limitations. First, the analysis uses an area-based measure for health 
literacy instead of individual assessments. While the area-based measured has been previously validated, 
individual assessments like the REALM46 or TOFHLA47 would have had less measurement error. 
However, standard assessments are unavailable for the cohort studied. Second, health literacy is highly 
correlated with socioeconomic status, and the findings may be driven in part by socioeconomic status 
instead of health literacy. The ADI was included in the analysis as a way to address this concern. But as 
an area-based measure, the ADI has similar drawbacks when being used as a proxy for individual 
deprivation. It is unclear whether the effects would have remained had we been able to control for 
individual socioeconomic status. Third, the analysis used claims data, so many individual characteristics 
were not observed in addition to health literacy. These individual characteristics that were not measured 
include: symptom status, disease severity, and anatomic variants. The analysis did include the Charlson 
Comorbidity index to control for medical comorbidity and an indicator for diabetes status to control for 
the different treatment guidelines for patients with diabetes.4 However, these measures do not directly 
control for the severity of the angina or symptoms the patient is experiencing. Fourth, the study included a 
random 20% sample of Medicare patients 65 and older with at least one month of simultaneous fee-for-
service coverage of Parts A, B, and D. As such, the results may not apply to Medicare beneficiaries 
younger than 65 or those who never had Part D or fee-for-service coverage. Fifth, multinomial logistic 
regression models were used as the main specification even though the Hausman-McFadden test for IIA 
was violated. Violation of this assumption may lead to bias in parameter estimates. Sixth, more 
observations were observed in earlier years of the analysis. This pattern may indicate that the ‘lookback’ 
period was not long enough and that prevalent cases of stable angina were included in the analysis. 
Alternatively, this finding may be due to how the sample was created. The diagnostic algorithm for 
identifying patients required multiple diagnoses to be included in the study sample. Patients were 
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assigned to the year in which the first diagnosis took place, which would assign the sample to earlier 
years than if the year for the second diagnosis were used.     
2.5.4. Conclusions 
 In summary, we found that an area-based measure for low health literacy was associated with a 
greater use of medication only and less use of PCI and CABG among patients with SAP. Patients living in 
low health literacy areas may benefit from receiving less invasive treatment given the recent trial results 
that question the benefit of PCI over medication only.31,32,45 Future research may yield more insights if 
individual assessments of health literacy and socioeconomic status become available in survey data sets 
with sufficient sample size.   
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2.6. Tables 
Table 2.1. Descriptive Statistics by Health Literacy Category 









Categorical Variables Level Freq (Pct) Freq (Pct) Freq (Pct) 
First Treatment 
Received 
Medication only 966 (59.2%) 6,539 (47.4%) 7,505 (48.6%) 
PCI 493 (30.2%) 4,974 (36.0%) 5,467 (35.4%) 
CABG 172 (10.5%) 2,291 (16.6%) 2,463 (16.0%) 
Sex 
Male 988 (60.6%) 7,235 (52.4%) 8,223 (53.3%) 
Female 643 (39.4%) 6,569 (47.6%) 7,212 (46.7%) 
Age 
65-70 477 (29.2%) 3,595 (26.0%) 4,072 (26.4%) 
70-75 355 (21.8%) 3,053 (22.1%) 3,408 (22.1%) 
75-80 324 (19.9%) 2,724 (19.7%) 3,048 (19.7%) 
80+ 475 (29.1%) 4,432 (32.1%) 4,907 (31.8%) 
RTI Race 
White 489 (30.0%) 12,417 (90.0%) 12,906 (83.6%) 
Black 644 (39.5%) 539 (3.9%) 1,183 (7.7%) 
Hispanic 403 (24.7%) 406 (2.9%) 809 (5.2%) 
Other 95 (5.8%) 442 (3.2%) 537 (3.5%) 
Diabetes 
No 737 (45.2%) 7,964 (57.7%) 8,701 (56.4%) 
Yes 894 (54.8%) 5,840 (42.3%) 6,734 (43.6%) 
Charlson Comorbidity 
Index 
0 928 (56.9%) 8,885 (64.4%) 9,813 (63.6%) 
1 358 (21.9%) 2,839 (20.6%) 3,197 (20.7%) 
2 193 (11.8%) 1,253 (9.1%) 1,446 (9.4%) 
3 103 (6.3%) 518 (3.8%) 621 (4.0%) 
4+  49 (3.0%) 309 (2.2%) 358 (2.3%) 
Year 
2007 554 (34.0%) 3,609 (26.1%) 4,163 (27.0%) 
2008 311 (19.1%) 2,516 (18.2%) 2,827 (18.3%) 
2009 205 (12.6%) 1,840 (13.3%) 2,045 (13.2%) 
2010 168 (10.3%) 1,483 (10.7%) 1,651 (10.7%) 
2011 128 (7.8%) 1,322 (9.6%) 1,450 (9.4%) 
2012 119 (7.3%) 1,314 (9.5%) 1,433 (9.3%) 
2013 146 (9.0%) 1,720 (12.5%) 1,866 (12.1%) 
Area Deprivation Index 
Category 
Low Deprivation 857 (54.0%) 11,844 (89.4%) 12,701 (85.6%) 
High Deprivation 730 (46.0%) 1,404 (10.6%) 2,134 (14.4%) 
Rural Status 
Urban 1,362 (83.5%) 10,140 (73.5%) 11,502 (74.5%) 
Rural 269 (16.5%) 3,664 (26.5%) 3,933 (25.5%) 
Continuous Variables  Mean (SD) Mean (SD) Mean (SD) 
Cardiologists per 10K   0.78 (0.54) 0.66 (0.60) 0.68 (0.59) 
PCPs per 10K   6.98 (2.43) 7.16 (2.88) 7.14 (2.83) 
Beds per 10K   37.77 (25.65) 33.76 (26.31) 34.18 (26.27) 
Full Dual Eligible*  44.4% (48.4%) 15.1% (35.0%) 18.2% (37.8%) 
Partial Dual Eligible*  11.3% (30.3%) 5.9% (22.6%) 6.4% (23.6%) 
Receives Low Income 
Subsidy* 
 
63.4% (47.6%) 25.4% (43.2%) 29.4% (45.2%) 
Area-Level Measure of 
Pct. Receiving PCI† 
 
34.1% (9.0%) 35.2% (9.7%) 35.1% (9.6%) 
Area-Level Measure of 
Pct. Receiving CABG† 
 
14.3% (5.5%) 15.0% (5.7%) 14.9% (5.7%) 
*Full dual eligible, partial dual eligible, and receives Low Income Subsidy are measured as the percentage of 
months that beneficiaries meet the criteria in the year following the index date. Note: CABG stands for coronary 
artery bypass grafting, PCI stands for percutaneous coronary intervention 
†These variables measure the percentage of patients receiving PCI or CABG at the hospital referral region level.  
  35 
Table 2.2. Marginal Effects for Multinomial Logistic Regression with Dichotomous Specification of 
















 ME (SE) ME (SE) ME (SE) ME (SE) ME (SE) 
Medication only 
Low Health Literacy 
(Basic/Below Basic) 
11.86%*** 3.33%* 3.36%* 2.94%* 2.90% 
(1.29%) (1.45%) (1.51%) (1.44%) (1.50%) 
Rural   
3.43%***  3.09%** 
  (1.03%)  (1.03%) 
ADI High 
Deprivation 
  0.10%  0.17% 
  (1.21%)  (1.20%) 
HRR PCI & CABG 
percentages 
   ✓ ✓ 
   
PCI 
Low Health Literacy 
(Basic/Below Basic) 
-5.81%*** -0.36% -1.02% 0.01% -0.59% 
(1.21%) (1.49%) (1.54%) (1.49%) (1.54%) 
Rural   
-1.74%  -1.38% 
  (1.04%)  (1.04%) 
ADI High 
Deprivation 
  1.11%  1.00% 
  (1.25%)  (1.24%) 
HRR PCI & CABG 
percentages 
   ✓ ✓ 
   
CABG 
Low Health Literacy 
(Basic/Below Basic) 
-6.05%*** -2.98%** -2.34%* -2.95%** -2.31%* 
(0.82%) (1.11%) (1.18%) (1.11%) (1.18%) 
Rural 
  -1.70%*  -1.71%* 
  (0.78%)  (0.78%) 
ADI High 
Deprivation 
  -1.21%  -1.17% 
  (0.95%)  (0.96%) 
HRR PCI & CABG 
percentages    
✓ ✓ 
Observations 15,435 15,435 14,835 15,435 14,835 
Standard errors in parentheses 
*** p<0.001, ** p<0.01, * p<0.05 
Note: ADI stands for area deprivation index. CABG stands for coronary artery bypass grafting, HL stands for 






Figure 2.1. Analysis File Flow Diagram. 
 
 
All Beneficiaries 2007-2014 
(N=5,558,582)
Beneficiaries Meeting Diagnostic 
Criteria (N=856,789 )
Beneficiaries Meeting Medication 
Criteria (N=199,045 )
No Prior Treatment (N=196,987)
Beneficiaries Without Excluding 
Diagnosis (N=106,642 )
12 Months Prior and Six Months Post 
FFS Coverage (N=46,442)
6 Months Post Part D Coverage 
(N=41,679)
Beneficiaries Merged to HL Measure 
(N=15,435)
Not meeting diagnosis criteria: 1) 2 diagnoses for stable angina; 
or 2) 2 diagnoses for coronary artery disease and 2 diagnoses for 
chest pain. (N=4,701,793) 
Beneficiaries in ‘Medication Only’ group that did not have at least 
one claim for nitrates in the year following diagnosis (N=657,744)
Beneficiaries with prior PCI or CABG (N=2,058 )
Beneficiaries with unstable angina (N= 22,698), myocardial 
infarction (N=23,231), or both (N=44,416) prior to index date
Beneficiaries without 12 months prior FFS (N=54,094), without 6 
months post FFS (N=1,393), and without 12 months prior FFS or 6 
months post FFS (N=4,713)
Beneficiaries without 6 months post Part D coverage (N=4,743)
Part D Claims 2007-2014
Beneficiary Summary File 2006-2014
Procedural Codes from MedPAR, 
Carrier, and Outpatient 2006-2014
Diagnosis Codes from MedPAR, 
Carrier, and Outpatient 2007-2014
ExclusionsData Source Step
Area-Based Health Literacy Measure 
Merged to 9-digit ZIP
Beneficiaries that did not merge to health literacy measure 
(N=26,244)
Diagnosis Codes from MedPAR, 
Carrier, and Outpatient 2007-2014
Beneficiary Summary File 2006-2014
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Figure 2.2. Predicted Probabilities of Treatment by Health Literacy Dichotomous Specification 
with Full Controls 
 
 
Figure 2.3. Predicted Probabilities of Treatment by Health Literacy Quartile Specification with 
Full Controls 
 
Note: The predicted probabilities are regression-adjusted. CABG stands for coronary artery bypass 
grafting, PCI stands for percutaneous coronary intervention.  
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CHAPTER 3. PATIENT-CLINICIAN TREATMENT PLANNING FOR STABLE 
ANGINA PECTORIS  
3.1. Overview 
Background: To characterize patient-clinician discussions to decide on treatment strategies for 
stable angina pectoris (SAP) and to determine whether health literacy affects communication.  
Methods: The analysis included a descriptive analysis of patient demographic and questionnaire 
data from the PCI Choice Trial, a randomized controlled trial that evaluated the impact of a conversation 
aid for SAP. A qualitative analysis was also conducted on recordings of patient-clinician discussions 
related to decision making for SAP. The recordings were coded with the OPTION12 instrument for 
shared decision-making. Two analysts independently assessed the number and types of patient questions 
and the number and ways patients expressed preferences for treatment.  
Results: Patients asked an average of four questions per encounter and only one quarter of 
questions (53/200) were related to clinical aspects treatment decisions. Clinicians had consistent patterns 
in their OPTION12 scores. Patients with inadequate health literacy had significantly higher decisional 
conflict than patients with adequate health literacy.  
Conclusions: Patients asked relatively few questions related to the clinical aspects of treatment 
decision. Clinicians had a large impact on the degree of shared decision-making. Health literacy and 
clinician communication may act as barriers to communication and could be intervention points to 
improve communication.  
3.2. Introduction 
Shared decision making (SDM) for medical decisions has become a prominent goal for the US 
healthcare system and has been endorsed as the ideal for patient-clinician interaction by the National 
Academy of Medicine.1,2 SDM is especially relevant when the ratio of risks to benefits for clinical 
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outcomes are similar and the optimal course of treatment may depend on how patients weigh the risk of 
complications or side effects, costs of treatment, and the disruption of medication only. Stable angina 
pectoris (SAP) is a common condition where treatment depends in part on patient preferences in addition 
to clinical presentation. Patients often misunderstand the risks and benefits of SAP treatment.3-5 SAP is 
typically caused by coronary artery disease, a condition that involves arteries leading to the heart being 
blocked by cholesterol plaque deposits. The arterial blockages reduce blood flow, and with increases in 
metabolic demand (e.g. exercise) patients may experience chest pain or tightness. The symptoms may 
restrict patients’ abilities to perform day to day activities. 
Patients who have SAP have three main treatment alternatives:  optimal medication only, 
percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG). The first 
alternative is medication only. Patients receive anti-anginal medications including long-acting nitrates, 
beta-blockers, calcium channel blockers, and ranolazine. The second alternative is percutaneous coronary 
intervention (PCI) plus medications. PCI involves a catheter being inserted into the blocked arteries. The 
plaque is pushed against the walls of the arteries and a coronary stent is implanted. Additionally, patients 
need to take the same anti-anginal medications. The third option is coronary artery bypass grafting 
(CABG) plus medications. Patients receive an invasive procedure (open heart surgery) in which an artery 
or vein from another part of the body is taken and grafted around the blocked arteries through an opening 
created in the chest. Patients may also receive the anti-anginal medications.6 Each alternative has key 
advantages and disadvantages. Medication only is non-invasive and less expensive. While long-term 
symptom relief with medication-only is comparable to PCI, PCI may have faster and more complete 
symptom relief. However, the recent ORBITA trial found no significant difference in exercise time 
between PCI and a placebo procedure.7 This finding challenges the idea that PCI produces faster short-
term symptom relief than medication only. PCI is more invasive and expensive than medication only, but 
it is much less invasive and expensive than CABG. CABG has relative fast symptom relief and also 
generally results in more complete symptom relief than PCI or medication only. However, it is much 
more invasive and expensive than PCI. Additionally, there is a small risk of death or other serious 
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complications. For these reasons, CABG is less commonly used than PCI for patients with SAP. CABG is 
typically reserved for patients with more severe blockages or specific co-morbidities such as diabetes for 
whom the practice guidelines judge the potential benefits to be worth the considerable risks of the 
procedure.6  
Notably, the outcomes in terms myocardial infarction and mortality are similar regardless of 
treatment decision for patients without left main coronary artery disease. The 2007 COURAGE trial, 
which excluded patients with left main disease, found no significant difference in terms of myocardial 
infarction or death for patients receiving medication only or PCI plus medication.8 While a decrease in 
use of PCI was observed following the trial results, the decrease was lower than expected.9-11 The 
relatively small impact may be due to patient confusion about the comparative effectiveness of the 
alternatives. Patients tend to mistakenly believe that PCI will lower the risk of myocardial infarction or 
death compared to medication only.3-5 This confusion may lead to lower use of medication only.  
This study examined patient-clinician discussions during treatment decision-making 
conversations for SAP. The study was a secondary analysis of data from the PCI Choice Trial, which was 
a randomized controlled trial that evaluated the impact of a conversation aid to facilitate shared decision 
making for SAP. The PCI Choice Trial found that use of the conversation aid improved patient 
knowledge about the comparative effectiveness of the treatment alternatives. However, the intervention 
did not improve the degree of SDM.12 Follow-up interviews found that clinicians were initially unfamiliar 
about SDM and uncomfortable changing their practice patterns.13 In particular, many clinicians used the 
conversation aid as an education tool rather than as a guide to support the conversation with the 
patient.12,13  
The main objective of this study was to use recorded patient-clinician discussions to understand 
how clinicians and patients communicate about the treatment alternatives. A secondary objective was to 
examine the potential role that health literacy plays in communication, including how conversations 
differed between patients with inadequate vs. adequate health literacy. We hypothesized that patients with 
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inadequate health literacy would have greater decisional conflict and less knowledge about the 
comparative effectiveness of treatment alternatives. 
3.3. Methods 
3.3.1. Data Source 
This analysis used data from the PCI Choice study, a randomized controlled trial to evaluate a 
conversation aid (PCI Choice) for treatment of SAP.12,13 The randomized trial enrolled 124 patients who 
received care at the general cardiology clinic or cardiac catheterization lab at the Mayo Clinic in 
Rochester, MN. Patients had to be eligible to receive either percutaneous coronary intervention or 
medication only. About half of the patients received the conversation aid (N=65) and half received usual 
care (N=59).:  
3.3.2. Measures  
 The PCI trial collected the following data: Patient questionnaires administered before, 
immediately after, and three months after the treatment selection discussion. The questionnaires assessed 
demographics, health literacy, patient knowledge, and treatment selection. Video and audio recordings of 
patient-clinician interactions. The recordings were only collected for a subset of patients (N=54) who 
consented. Additional details about the trial are available through the study protocol and the results of the 
trial.12,13 
 Shared decision-making (SDM) was assessed using the OPTION12 Scale, which is a 12-item 
scale that rates the clinicians’ actions to promote SDM. The OPTION12 ranges from 0 (low SDM) to 100 
(high SDM). It has been validated14 and used for a variety of medical conditions including cardiovascular 
disease.15 The methods for the collection were described in a previous study.12 Briefly, the OPTION12 
was collected by two independent reviewers and concordance was assessed using the Lin concordance 
correlation coefficient. The concordance between the two reviewers was found to be high.12 
Outcome measures were assessed via the patient questionnaire. The first outcome was patient 
knowledge of angina and the treatment alternatives. The assessment consisted of ten questions asked 
immediately following the treatment discussion. The questions related to information patients should 
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understand after discussing treatment options with their clinician. These questions were developed for the 
original study with input from cardiologists who treat patients with SAP.12 The second outcome was the 
Decisional Conflict Scale (DCS), which is a 16-item scale used to measure patient perception of 
uncertainty and effective decision making. The Scale ranges from 0 (low conflict) to 100 (high conflict). 
The DCS has been validated16 and applied to cardiovascular disease.17  
Health literacy was assessed using a validated screening question: “How confident are you filling 
out healthcare forms by yourself?”18,19 Patients were defined as having ‘inadequate’ health literacy if they 
answered “Somewhat,” A little bit,” or “Not at all.”18,19 Otherwise, patients were classified as having 
‘adequate’ health literacy. Previous research has demonstrated that this screening question has good 
sensitivity and specificity for identifying inadequate health literacy relative to validated instruments 
including the S-TOFHLA and REALM.19  
3.3.3. Patient Engagement Measures 
Two patient engagement measures were defined for analyzing the recorded encounters. These 
measures were created for this study to capture information unique to these treatment conversations. The 
measures of patient engagement were: 1) the number and type of questions patients asked; and 2) the 
number of times the patient expressed their preferences on treatment. The categories for type of questions 
appears in the Analytic Approach section. The preferences included stated preferences for any aspect of 
treatment such as type of therapy and timing of treatment.  
3.3.4. Sample Selection 
The sample selection process is illustrated in Figure 3.1. The full sample and the recording 
sample are indicated separately because some measures were only available for the recording sample. The 
two exclusions were for missing values for the health literacy questionnaire items and limiting to patients 
who had their encounter recorded. The final samples were 118 for the full sample and 53 for the recording 
sample.   
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3.3.5. Statistical Methods 
 Two reviewers assessed the patient engagement measures and extracted quotes from the 
recordings. To establish a consistent reviewing process, both reviewers first assessed ten recordings. The 
interrater reliability was assessed using the intraclass correlation coefficient (ICC).20 After assessing 
interrater reliability, discrepancies were discussed and the remaining recordings were divided among the 
two reviewers.  
The patient engagement question types were collapsed into two categories: questions related to 
clinical aspects of treatment selection and questions related to logistics and clarification. The categories 
were collapsed to these two categories due to the results of the inter-rater reliability assessment. The first 
category included questions about: 1) the risk of myocardial infarction or death, 2) the complications or 
side effects of treatment, and 3) symptom relief. The second category included questions about: 1) 
logistics and 2) clarification. Logistics questions related to issues such as how long a coronary angiogram 
would take or whether a follow-up appointment was necessary. Clarification questions related to asking 
the clinician to explain information that had already been presented, but that the patient did not 
understand. The ICC was excellent (0.75-1) for the total number of questions asked at each encounter. 
However, the ICCs were poor (0-0.4) for some of the sub-categories of questions. When the questions 
were grouped into the larger categories, the ICCs were excellent.  
The results were analyzed using descriptive statistics. Key findings were illustrated using quotes 
from the recordings. The results for the knowledge questions and the DCS were compared for the 
inadequate and adequate health literacy groups. The mean and distribution were compared and ordinary 
least-squares regression was used to assess whether there were statistically significant differences by 
health literacy level controlling for the arm of the study.  
The OPTION12 Scale was evaluated at the clinician-level because the items related more to 
clinician behavior than patient behavior. The analysis of the OPTION12 results was restricted to the three 
clinicians who treated at least five patients in the study because it would be difficult to establish 
OPTION12 patterns for clinicians who had fewer than five study patients.  
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3.3.6. Sensitivity Analysis 
An alternative specification for health literacy used two additional questions (Appendix Table 
12). The responses for all three questions were added together to form a scale from 0-12 points and 
patients with six or fewer points were defined as having ‘inadequate’ health literacy.19 The main 
specification is recommended because adding the two additional questions does not improve sensitivity or 
specificity.19 The purpose of the sensitivity analysis was to assess whether the differences in patient 
knowledge and decisional conflict by health literacy category were dependent on which health literacy 
specification was used.  
3.4. Results 
3.4.1. Descriptive Statistics 
Sample characteristics for the full sample and recording sample appear in Table 3.1. A majority 
of patients in both samples were male. Patients with inadequate health literacy were slightly older and 
more likely to only have a high school degree or less for educational attainment (73% vs. 20% and 80% 
vs. 19%). Encounters were longer among patients with inadequate health literacy (19.85 vs. 13.75 
minutes in the recording sample). Most patients in the recording sample had a caregiver or family 
member attend with them (90% vs. 74%).  
3.4.2. Patient Questions 
 Patients asked relatively few questions related to the clinical aspects treatment selection (Figure 
3.2.). Most questions either asked about logistics of how the angiogram or PCI would work or 
clarification about information that was already presented. An example of a question that relates to 
treatment selection is shown in Box A. This question asks about how patients experience symptom relief 
with PCI (stenting), which may affect the decision of whether to receive PCI.  On average, patients asked 
3.8 questions per encounter and only 24% (0.89 per encounter) of these questions were categorized as 
relevant to clinical aspects of treatment selection. About half of patients (27/53) asked no questions 
Box A: 
Patient: "Do you feel better after you have a stent typically? Or is it just basically that you don't 
notice anymore differences? " 
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relevant to the clinical aspects, and a quarter asked only one such question (14/53). Patients who received 
PCI or CABG tended to ask more questions than patients who received medication only (1.3 vs 0.4) This 
difference was statistically significant (p=0.012) using a Wilcoxon rank-sum test.  
3.4.3. Patient Expressions of Preference 
 Most patients expressed at least one preference towards treatment (49/53). On average, patients 
expressed about two preferences per encounter (109 preferences and 53 encounters). Most preferences  
were prompted by the clinician asking the patient for input (75/109). Over a third of patients did not 
express any preferences that included a rationale (19/53). In these instances, the patients would state their 
preferences without explaining why they felt that way. In some of these cases, the patients would defer 
decision-making responsibility to their clinician, as in Box B, where the patient expresses a preference for 
the clinician to make a treatment recommendation.  
3.4.4. Clinician Communication Patterns 
 In the recordings, the analysts observed that clinicians who had multiple recorded encounters 
appeared to have consistent approaches used for engaging patients. Some clinicians appeared to have 
consistent approaches used for engaging patients. One behavior that frequently arose was clinicians that 
asked patients leading questions, as in Box C.  
The clinician appears to be leading the patient to choose the option with faster symptom relief 
(PCI) by focusing on the advantage of PCI over medication only. Other clinicians made sure to ask 
questions in a more balanced way, as in Box D. 
Box C: 
Clinician: "So really, it's all about how long you really wanna wait to have your symptoms relieved. 
Do you want immediate…or do you want…?"  
Patient: "I want immediate."  
Clinician: "All right, that kind of tells me the answer then here." 
Box B: 
Clinician: "I guess, you know, I will be guided by you. But if you felt that you really can't make a 
decision, I am happy to suggest."  
Patient: "I was going to say, if you were me, what would you do at this juncture?"  
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In Figure 3.3., the OPTION12 scores reflecting low versus high SDM for the three clinicians are 
consistent with the observations from the recordings. Two of these clinicians (Clinicians 1 and 3) 
practiced in the cardiac catheterization lab and one (Clinician 2) practiced in the general cardiology 
clinic). Clinician 1 had consistently low SDM (OPTION12 scores below 25) for 11/12 patients. In 
contrast, Clinician 2 had consistently high SDM (above) for all 4/8 patients and had no scores below 20. 
While Clinician 1 and 2 had relatively consistent scores, Clinician 3 had six encounters with low SDM 
and two with high SDM. Clinician 3 also had a wide range in scores (4 for the lowest and 29 for the 
highest). However, the relative inconsistency for Clinician 3 may be explained by whether conversation 
aid was used in the encounter. Clinician 3 had the four lowest SDM scores for all four patients that 
received usual care and had the four highest SDM for all four patients that received the conversation aid.  
3.4.5. Outcome Measures by Health Literacy Level 
Patients with inadequate health literacy were more likely to receive PCI or CABG following the 
encounter (Table 3.1) than patients with adequate health literacy. Half of patients (11/22) with inadequate 
health literacy received PCI or CABG while only around a third of patients (31/96) with adequate health 
literacy received either procedure. However, this difference was found to be statistically insignificant 
using a Fisher’s exact test (p=0.24). 
Patients showed a moderate but somewhat varied level of understanding in terms of their 
performance on the knowledge questions (Figure 3.4.). On average, patients responded correctly to 55% 
of the questions. Patients performed slightly worse than average for the questions on whether PCI would 
reduce the risk of myocardial infarction or death relative to medication only (51%) and whether patients 
who receive medication only have similar symptom relief compared to PCI at one year (46%). The mean 
and distribution of questions answered correctly were similar for patients by health literacy level (54.2% 
Box D: 
Clinician: “So based on that conversation, what do you think? I'm gonna take pictures today -and if I 
have a choice between medicines or stenting to make you feel better, which one do you think would 
be the right choice for you?” 
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for inadequate health literacy and 56.3% for adequate health literacy) and the regression coefficient 
(Table 3.2) for inadequate health literacy was not statistically significant (p=0.34).  
 Unlike the knowledge responses, decisional conflict appeared higher among patients with 
inadequate health literacy (Figure 3.5). The average DCS was greater among patients with inadequate 
health literacy (23.6 vs. 18.4). Similarly, the percentage of patients with DCS greater than 25 (68% vs. 
50%) was also higher in the inadequate health literacy group. A Wilcoxon rank-sum test between health 
literacy and decisional conflict was statistically significant (p=0.019) and a regression coefficient (Table 
3.2.) for inadequate health literacy was not quite statistically significant (p=0.051).  
 As noted above, the alternative specification for health literacy was used as a sensitivity analysis. 
The results were mostly consistent, although the rank-sum test became insignificant for DCS (p=0.18). 
However, the lack of statistical significance is partially due to fewer people being identified as having 
inadequate health literacy (11 vs. 19).   
3.5. Discussion 
3.5.1. Summary of Findings 
This study provides a novel characterization of patient-clinician discussions using recorded 
conversations. We found that most patient questions had to do with contextual or clarifying information. 
Many patients asked no questions related to clinical aspects of the treatments. Patients were only able to 
answer about half of knowledge questions correctly. This suggests that patients may have not had a clear 
understanding of the treatment alternatives when expressing their preferences for treatment. We also 
found that clinicians had consistent patterns in their OPTION12 scores. Among the three clinicians with 
at least eight encounters, SDM was consistently low or high for the same clinician. This finding suggests 
that clinicians may have distinct communication styles that are consistent across the patients they treat. 
Alternatively, this pattern may be explained by the setting in which the encounters took place. The 
clinician with consistently high scores practiced in the general cardiology clinic whereas the clinicians 
with consistently low practiced in the cardiac catheterization lab. Patients seen in the cardiac 
catheterization lab are at a later stage of the treatment process and at this point the decision to receive PCI 
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may have been made. Lastly, we assessed the potential effects of health literacy on knowledge and 
decisional conflict. Patients with inadequate health literacy had significantly higher decisional conflict 
than patients with adequate health literacy. Surprisingly, inadequate health literacy was not associated 
with less knowledge.  
 To our knowledge, this is the first study to directly characterize patient-clinician interactions 
among SAP patients. Several previous studies have analyzed patient-clinician discussions for other 
medical decisions.21,22 One study analyzed recorded clinician-patient interactions for rectal cancer 
treatment planning with an approach that was similar to the current study. The authors found that patient 
values were expressed in fewer than half of the interactions and that patient treatment preferences were 
expressed in fewer than a quarter of interactions.21 These findings are consistent with the current study’s 
findings of relatively low patient involvement in treatment planning. While patient preferences were more 
commonly expressed in this study, the difference was likely due to having less restrictive criteria for what 
qualified as a preference. Another study conducted a systematic review of OPTION12 scores for a variety 
of conditions.15 The mean OPTION12 score in this study (19.5) was similar to the mean score in the 
systematic review (23).15 Previous studies have also examined the relationship of health literacy with 
treatment planning. However, a scoping review of the literature found too many inconsistencies to make 
conclusions about health literacy and treatment decision-making.23 More consistent research is needed to 
understand how the results in this study relate to health literacy and decision making in general.  
3.5.2. Limitations 
This analysis has several limitations. First, the sample size was small and few patients were 
categorized as having inadequate health literacy (10/52 for the recording sample, 22/118 for the full 
sample). Given the small sample size and descriptive nature of the analysis, the findings should be 
interpreted as exploratory. Second, the analysis did not include racial or ethnic minorities in the recording 
sample and only one in the full sample. An extensive literature indicates that patient-clinician 
communication differs when the patients are racial or ethnic minorities.24,25 Caution is warranted when 
considering how the results apply to other populations. Third, the analysis took place at the Mayo Clinic, 
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which is a premier health care delivery system. The results may be different for other health systems, 
especially those that have different cultures or serve different patient populations. Fourth, the OPTION12 
score may not fully reflect whether meaningful SDM between patients and clinicians actually occurred. It 
was observed that in encounters with the conversation aid some clinicians would go through the steps of 
the aid in a mechanical fashion and still receive relatively high OPTION12 scores. Fifth, the health 
literacy measure uses a screening question instead of an instrument such as the S-TOFHLA or REALM. 
While the screening question has been validated against these instruments, it still is less accurate and is 
based upon patient self-report of their literacy skills instead of a more objective assessment.18,19 A 
particular concern is that the response to the screening question may be associated with the DCS since 
they both relate to confidence. However, a sensitivity analysis that used two additional questions in 
defining health literacy found largely consistent results.  
3.5.3. Conclusions 
This analysis provides key insights into what takes place in patient-clinician discussions for SAP 
in the context of a clinical trial of an SDM intervention. These findings have important implications for 
understanding how patients and clinicians discuss medical decisions that require important tradeoffs. The 
results also suggest possible targets for intervention including patients with inadequate health literacy and 
clinician communication. Future research could confirm the findings for different and larger populations.  
The findings from this study suggest potential targets for intervention. We found that patients 
asked relatively few questions about the clinical aspects of treatment selection and patients with lower 
health literacy had higher decisional conflict. One potential way to address these issues would be to have 
more time available, especially for patients with inadequate health literacy. OPTION12 scores tend to be 
higher when consultations are longer.15 The additional time may help the patients and clinicians feel less 
rushed and give the patient more opportunities to ask questions. We also found that particular clinicians 
seemed to have consistent effects on the degree of SDM in the discussions. A potential explanation is that 
it was the setting of care that affected the degree of SDM (cardiac catheterization lab vs. general 
cardiology clinic). One way to address this issue would be move the treatment selection discussion to an 
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earlier stage since the decision may have already been made by the time patients reach the cardiac 
catheterization lab. An alternative explanation is that clinicians had particular communication patterns 
that encouraged or discouraged SDM. One intervention to encourage clinicians to involve patients more is 
a conversation aid, which was the main goal of the PCI Choice conversation aid. However, the results of 
the trial were somewhat disappointing. While patients in the treatment arm had a significant improvement 
in knowledge scores, significant improvement did not occur in OPTION12 or DCS scores.12 Follow-up 
interviews with clinicians involved in the study found that many of the clinicians were confused about 
how SDM differs from patient education.13 This finding is consistent with the observation that many 
clinicians appeared to be using the conversation aid as an education tool rather than a guide to encourage 
discussion. Therefore, conversation aids such as PCI Choice may be still be effective when paired with 
additional training for clinicians.  
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3.6. Tables 
Table 3.1. Descriptive Statistics for Full Sample and Recording Sample by Health Literacy 
Category 
   Full Sample (N=118) Recording Sample (N=52) 
















Variable Units Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Age at Visit Years  68.1 (10.3) 71.5 (11.2) 68.2 (10.3) 73.0 (10.4) 
Discussion 
Length Seconds   824.7 (482.1) 1191.0 (902.6) 
Variable Value Freq (Percent) Freq (Percent) Freq (Percent) Freq (Percent) 
Patient 
Gender 
Female 28 (29%) 4 (18%) 10 (23%) 2 (20%) 
Male 68 (71%) 18 (82%) 33 (77%) 8 (80%) 
Educational 
Attainment 
High school or less 19 (20%) 16 (73%) 8 (19%) 8 (80%) 
Some college or 
associates degree 38 (41%) 5 (23%) 17 (40%) 2 (20%) 
College graduate or 
graduate/prof. 




PCI  24 (25%) 9 (41%) 16 (37%) 4 (40%) 
CABG 7 (7%) 2 (9%) 2 (5%) 0 (0%) 
Neither PCI nor 




Private 29 (30%) 7 (33%) 13 (30%) 2 (20%) 
Medicare 47 (49%) 12 (57%) 24 (56%) 8 (80%) 
Medicaid 2 (2%) 2 (10%) 1 (2%) 0 (0%) 




No NA NA 11 (26%) 1 (10%) 
Yes NA NA 32 (74%) 9 (90%) 
Treatment 
Arm 
Usual Care 47 (49%) 8 (36%) 18 (42%) 3 (30%) 
Conversation aide 49 (51%) 14 (64%) 25 (58%) 7 (70%) 
Note: SD stands for standard deviation, CABG stands for coronary artery bypass grafting, PCI stands for 
percutaneous coronary intervention.  
  
 56 
Table 3.2. Regression Output for Knowledge Questions and Decisional Conflict Scale 




Adequate Health Literacy -4.72 (4.92) 5.67 (2.88)* 
Study Arm—Conversation aid 22.58 (4.48)*** -2.60 (2.76) 
Constant 43.54 25.42 
***p<0.01, **p<0.05, *p<0.1 






Figure 3.1. Sample Flow Diagram 
 
Note: The sample for some analyses is smaller due to missing data on outcome variables.  
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Figure 3.2. Topics of Patient Questions (N=200) Asked at Encounters (N=53) 
 
Note: ‘Clarification’ questions included questions that were tied to the logistics of treatment, but not the clinical 
aspects of decision-making. For example, one question in this category was about how the diagnostic angiogram 
would work and how long it would take. ‘Other’ questions related to information that was not directly relevant to the 
treatment of stable angina pectoris. Some questions included in the ‘Other’ category were about comorbid 




Figure 3.3. OPTION12 Scores for Clinicians with 8+ Encounters 
 
Note: Shows OPTION12 Scores for Shared decision-making for the three clinicians in the study with eight or more 
patient encounters.  
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Figure 3.4. Distribution of Correct Responses to Knowledge Questions  
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CHAPTER 4. MEDICATION ADHERENCE FOR STABLE ANGINA PECTORIS: THE 
ROLE OF HEALTH LITERACY AND TREATMENT ASSIGNMENT  
4.1. Overview 
Background: Many patients have low adherence to medications used to treat cardiovascular 
diseases including stable angina pectoris (SAP). SAP represents a condition where procedures and 
pharmaceutical only treatments have similar outcomes. Physicians may recommend treatments for 
patients based on their expectations about patient adherence to medications, and these expectations may 
be formed by their assessment of patient characteristics such as health literacy. We aim to account for this 
potential treatment selection and identify the effects of area-based health literacy on medication 
adherence. 
Methods: Observational analysis of Medicare fee-for-service (FFS) beneficiaries (20% random 
sample). The sample identified beneficiaries with an incident diagnosis of SAP from 2007-2013. The 
health utilization outcome was a dichotomous measure for whether beneficiaries were adherent to anti-
anginal medications over the year following initial diagnosis. Treatment alternatives included: medication 
only, percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG) surgery. 
Health literacy was constructed as an area-based measure due to lack of an individual measure in claims 
data. Three different approaches were used to estimate relationships between health literacy and 
medication adherence while adjusting for treatment selection: 1) probit regression, 2) inverse probability 
of treatment weighting with probit regression, and 3) two-stage residual inclusion. The instrumental 
variables used for the last approach were two area-based measures for the proportion of patients receiving 
CABG and PCI at the hospital referral region (HRR) level.  
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Results: Mean adherence was 78.7% in the first six months and 67.0% in the second six months. 
Living in a low health literacy area was significantly associated with a decrease in adherence for the 
quartile specification of health literacy (marginal effects ranged from -2.6 percentage points to -4.6 
percentage points) but not the dichotomous specification. The results were similar in the models that 
controlled for selection compared to the results in the models that did not control for selection. 
Conclusion: Lower health literacy measured at the community level was associated with lower 
medication adherence, though the differences between the quartile and dichotomous versions meant this 
finding was not robust. The limited findings do not support the hypothesis that health literacy is an 
important factor in medication adherence. Further evaluation of health outcomes (rather than just 
medication adherence) may be fruitful.  
4.2. Introduction 
Poor adherence to medications is a common problem in the treatment of chronic cardiovascular 
disease. One study found that among patients with coronary artery disease, only about 46% and 44% of 
patients reported persistent use of beta-blockers and lipid-lowering medications, respectively.1 Another 
study found that among patients with coronary artery disease, two-year adherence to statins was only 
about 40%.2 Poor adherence to medications can have important health consequences. For CAD patients, 
non-adherence to beta-blockers, ACE-inhibitors, and statins was associated with higher mortality, 
cardiovascular hospitalization, and revascularization.3 Given the high prevalence of non-adherence and 
the value of adherence for health outcomes, it is important to understand the predictors of poor adherence. 
Understanding the factors that predict low adherence may help inform educational and other interventions 
to promote safe and appropriate medication use.  
Low health literacy has been identified as a potential factor affecting adherence.4 Health literacy 
is defined as “the degree to which individuals have the capacity to obtain, process, and understand basic 
health information and services needed to make appropriate health decisions.”5,6 Low health literacy is 
associated with advanced age, lower educational attainment, racial and ethnic minorities, and speaking 
English as a second language.7 Patients with low health literacy have reduced skills needed for disease 
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management. In the context of medication use, patients with low health literacy have more difficulty 
reading and interpreting instructions for taking prescription medications.8 However, the evidence of a 
relationship between health literacy and medication adherence is mixed. Two recent systematic reviews 
found insufficient evidence to make a conclusion about the relationship.4,9 In contrast, a systematic review 
conducted a meta-analysis and found that low health literacy was significantly associated with a decrease 
in medication adherence, but the effect size was small.10 All three studies emphasized the need for more 
research.4,9,10 
In this analysis, we focused on the treatment of patients with stable angina pectoris (SAP). 
Patients with SAP receive anti-anginal medications including beta-blockers, calcium channel blockers, 
nitrates, and ranolazine. These medications are taken to relieve the symptoms of angina.11 In addition to 
the medications, patients may also receive percutaneous coronary intervention (PCI) or coronary artery 
bypass grafting (CABG) surgery. PCI involves a catheter being inserted into the blocked arteries. The 
plaque is pushed against the walls of the arteries, and a coronary stent is implanted to prevent the arteries 
from becoming blocked again. Coronary artery bypass grafting (CABG) surgery involves open heart 
surgery in which an artery or vein from another part of the body is taken and grafted around the blocked 
arteries through an opening in the chest. PCI or CABG patients generally receive the same medications to 
address symptoms as patients who receive only medications.11 Patients who receive PCI must also take 
and remain adherent to dual antiplatelet therapy.12 Failure of PCI recipients to maintain adherence to dual 
antiplatelet therapy is associated with an increased risk of stent thrombosis, which is a serious 
complication that often leads to myocardial infarction and death.12,13 Patients who receive CABG often 
experience more complete symptom relief.14-16 Although CABG is associated with lower risk of major 
adverse cardiovascular events, it is typically reserved for patients with more complex coronary artery 
disease than just SAP..14,17 
Given the limited differences in clinical outcomes between the treatment alternatives, selection by 
physicians (or joint choice though shared decision making by physicians with patients) into treatment is 
likely. Treatment selection is certainly based on clinical factors, including clinical presentation of the 
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coronary artery disease and relevant co-morbidities such as diabetes.11,18 Yet selection may also be based 
on other factors, such as physician expectations about the ability of patients to remain adherent to 
medications. Because adherence to dual antiplatelet therapy is so important for preventing complications 
among patients that receive PCI,12,13 physicians may attempt to limit this procedure to patients who they 
believe will be able to maintain high adherence. Physicians may also encourage patients with expected 
poor medication adherence to receive CABG, since patients with poor medication adherence have better 
outcomes with CABG.19 To determine how health literacy is associated with medication adherence it is 
important to address the possible selection into treatment.  
We aimed to identify the relationship of health literacy with medication adherence. First, we 
assessed the relationship assuming no selection into treatment. Then, the relationship was assessed using 
inverse propensity of treatment weights (IPTW), where the weights are based only on observed variables. 
Third, we attempted to address selection based on unobservable variables using an instrumental variable 
approach (two-stage residual inclusion). The instrumental variables for treatment assignment were area-
based measures for the proportion of patients receiving PCI and CABG at the hospital-referral region 
level. We hypothesized that lower health literacy would be associated with lower medication adherence. 
We believed that physicians would select patients they expect to be more adherent into PCI due to the 
need to remain adherent to dual antiplatelet therapy and they would select patients they expect to be less 
adherent into CABG because the treatment achieves more complete symptom relief even if patients are 
not adherent to the medications.  
4.3. Methods 
4.3.1. Data Sources 
The primary data source for this analysis was a 20 percent random sample of Medicare claims for 
beneficiaries aged 65 and older who had at least one month of simultaneous enrollment in fee-for-service 
Parts A (hospital), B (outpatient medical), and D (prescription drug) between 2007-2013. Claims from 
2006 were used to identify and exclude patients who had SAP before 2007. In addition to the claims, the 
following data source were used: 1) the Area Health Resource File (AHRF),20  2) health literacy estimates 
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at the census block group level,7,21 and 3) an area deprivation index (ADI) at the 9-digit ZIP Code level.22 
The ADI is a neighborhood-level measure for socioeconomic status. The ADI for this analysis was 
derived from 2000 Census data and it incorporated variables including education, income, employment, 
and housing.22,23 The AHRF includes variables on regional medical supply, socioeconomic status, and 
health status.20  
 The sample selection process appears in Figure 4.1. Briefly, the steps were used to identify 
patients with incident diagnosis of SAP who were receiving medications to provide symptom relief for 
SAP. These medications included beta-blockers, calcium channel blockers, long-acting nitrates, and 
ranolazine.11 To ensure that the sample included patients who were receiving medications, one sampling 
criterion was that patients had to have at least one claim for any of these medications in the first six 
months following diagnosis. While the step helped to ensure the sample had a physician prescribe 
medication, this step excluded patients with such low adherence that they did not fill any claim for these 
medications even though a physician may have prescribed them. Information on the procedural and 
diagnosis codes used to identify the sample appear in Appendix Tables 13-15.  
4.3.2. Variable Selection 
 The dependent variable was a dichotomous indicator for whether the patient was adherent to the 
medications for SAP over the year following initial diagnosis. Adherence was measured separately over 
the first six months and the second six months following diagnosis using proportion of days covered 
(PDC).24 A patient was considered adherent on a given day if they had an active fill for a prescription to 
any of the medications for SAP.  A patient was considered adherent for the six-month period if they had a 
PDC of 80% or higher.25    
Due to lack of an individual measure of health literacy in claims data, health literacy was 
measured using an area-based variable. The measure was calculated using a predictive model published in 
the literature that was based upon the 2003 National Assessment of Adult Literacy (NAAL).7,26 This 
model included the following demographic characteristics: gender, age, race/ethnicity, education, income, 
marital status, language spoken at home, rurality, and time living in the US.7 The demographic measures 
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for this study were derived from the 2010 US census.21 The model has been validated in prior research.7,21 
The predicted health literacy scores are categorized into four NAAL designations: below basic (0-184), 
basic (185-225), intermediate (226-309), and proficient (310-500). The designations correspond to 
particular skills that individuals at those levels are able to perform.27 In this study, the variable was 
operationalized in two alternative ways: a dichotomous measure, and quartiles based on the national 
distribution of values at the census block group level. Previous studies focused on a dichotomous 
categorization of “Above Basic” or “Basic/Below Basic” based on NAAL categories.7,21 In this study, 
“Above Basic” will be referred to as “high health literacy” and “Basic/Below Basic” will be referred to as 
“low health literacy.” The quartile specification was also used since it allows for a more detailed 
assessment of the pattern of association of health literacy with medication adherence.   
 Treatment was a categorical variable for the initial treatment the patients received: medication 
only, PCI, or CABG. Patients were assigned as PCI or CABG if they had the procedure within a one year 
following the index date of initial diagnosis. For patients who received both PCI and CABG, the patient 
would be assigned to the treatment they received first. Patients who did not receive PCI or CABG within 
the first year were assigned to medication only.  
The study also included the following control variables: race/ethnicity (white, black, hispanic, 
and other),28 sex, age, the Deyo version of the Charlson comorbidity index,29 and an indicator for whether 
the patient had diabetes. Diabetes was measured separately because the comparative effectiveness of 
treatment alternatives for SAP varies for patients with diabetes.18  Diabetes was excluded from the 
Charlson comorbidity index to avoid double-counting. In addition to the individual-level variables, the 
analysis also included county-level measures of primary care physicians, cardiologists, and hospital beds 
per 10,000 residents to account for differences in regional medical supply. Year fixed effects were 
included to control for time trends.  
In the main analysis, rural status and the Area Deprivation Index (ADI)22,23 were not included 
because the predictive model used to create the health literacy measure included area-based variables for 
rurality and income.7 We expected these variables to be highly correlated with the health literacy 
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measure, so they were added in additional specifications of the models. Rural status came from the AHRF 
and was determined at the county-level. The ADI was also specified as a dichotomous variable30 and as 
quartiles based on the national distribution. The dichotomous ADI version was used in the specifications 
that used the dichotomous health literacy measure, and the quartile ADI version was used in the 
specifications that used the quartile health literacy measure.  
4.3.3. Statistical Methods 
 The first estimation approach was a probit regression that included treatment and area-based 
health literacy as the key explanatory variables. The results are presented in terms of average marginal 
effects and the standard errors were clustered at the patient level to account for multiple observations (the 
first and second six month periods). 
 The second approach was a probit regression that included inverse probability of treatment 
weighting (IPTW) to adjust for treatment selection based on observed variables. Propensity score analysis 
has been most commonly applied to analyses that include two treatment levels.31,32 Propensity score 
analysis can be extended to three or more treatment groups by using the generalized propensity score.33 
The generalized propensity score (P(Ti=t|X)) is defined as the probability that the patient receives the 
treatment they were assigned (Ti=t) to conditional on observed covariates (X). The weights (wi) for IPTW 





In this analysis, the propensity scores were calculated using generalized boosted modeling (GBM).34,35 
Briefly, GBM is an iterative approach that uses regression trees to identify improvements to the model 
after each iteration. A key advantage of GBM is that interactions and higher order terms are automatically 
generated. In addition, GBM often performs better than approaches such as logistic regression where the 
analyst needs to specify the functional form directly.34,35  
 GBM was implemented in ‘R’ using the package ‘twang.’ The standardized mean differences for 
the unweighted and weighted samples for one of the specifications appears in Appendix Table 16. The 
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standardized mean difference was used to evaluate the success of the weighting. Generally, a cutoff of 0.1 
has been used to assess standardized mean differences.31,32 Before weighting, the standardized mean 
differences were 0.1 or greater for 15/75 comparisons. After weighting, only 4/75 comparisons had values 
of 0.1 or greater. In addition, Figures 4.2., 4.3, and 4.4 show the density plot for the propensity scores by 
each treatment alternative. The plots show a large degree of overlap, which suggests sufficient common 
support. After calculating the weights, they were incorporated into the probit regressions as sampling 
weights. The regressions included the same control variables that were used to create the propensity 
scores. Including the control variables after applying IPTW controlled for residual confounding36-38 and 
made the model ‘doubly-robust.’36 The standard errors were clustered at the patient level to account for 
multiple observations (the first and second six month periods). 
 The third approach was instrumental variable (IV) analysis using two-stage residual inclusion 
(2SRI).39 Unlike the two previous approaches, this approach directly attempted to model the selection into 
treatment. 2SRI involves a first-stage model in which the endogenous treatment variable (PCI, CABG or 
medication only) is the dependent variable, which is regressed on the instrumental variable(s) and the 
exogenous regressors. The residuals from the first stage are calculated and then included in the second 
stage regression in addition to the endogenous regressor.39 2SRI is consistent when used for non-linear 
models, whereas two-stage predictor substitution (i.e., the equivalent of two-stage least squares for non-
linear models) is not a consistent estimator.39 In this analysis, the first stage was a multinomial logistic 
regression model because the endogenous variable was the three-category treatment assignment 
(medication only, PCI, or CABG). Medication only was used as the reference category, and the residuals 
were calculated as one minus the predicted probability of receiving the treatment if the patient received 
that treatment and zero minus the predicted probability of receiving the treatment if the individual 
received a different treatment. The residuals were calculated separately for PCI and CABG and then the 
raw residuals included in the second stage probit regression in addition to the categorical treatment 
variable. To obtain accurate standard errors that accounted for the first stage regression, we computed the 
standard errors using 500 bootstrap replications. 
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The instrumental variables used in this analysis were two area-based, time-varying measures that 
were calculated at the Hospital Referral Region (HRR) level. In previous research, physician treatment 
patterns have been used as IVs.40 In this analysis, the treatment patterns were calculated at a regional level 
because patients may have had claims with different physicians based on the treatment they were assigned 
to, so it would not have been possible to examine treatment patterns at the physician level. The measures 
were calculated as three year moving averages, which ensured that a sufficient number of observations 
were available for each HRR and to allow changes in treatment patterns over time. To calculate the 
measures, all patients were included except for the patient for whom the calculation was being made. The 
reason for excluding the patient was so that the proportion of patients receiving PCI or CABG was not 
changed by the patient’s own treatment status.  
 IV analysis makes three assumptions.41 The first assumption is that the IVs must be strongly 
related to the endogenous regressors. The use of instruments that are only weakly associated with the 
endogenous variables can lead to biased results.42 This assumption is often tested using an F-statistic of 
the IVs in the first stage.43 In this analysis, the first-stage was a multinomial logistic regression model, so 
a chi-square test was used to test whether all the coefficients for the IVs were equal to zero. In all 
specifications, the null was strongly rejected (p<0.001). The next assumption (endogeneity) is that the 
endogenous regressor is actually endogenous. This assumption is often tested by including both the 
residuals from the first stage in addition to the endogenous regressor and assessing the statistical 
significance of coefficients on the residual terms.44 However, this test is only applicable to linear models. 
The assumption can still be assessed by comparing the marginal effects from the 2SRI model with the 
marginal effects from the first approach that ignores selection. The last assumption (exclusion restriction) 
is that the IVs do not belong in the second stage regression.45 This assumption cannot be tested directly 
when the system is exactly identified (i.e., the number of endogenous regressors equals the number of 
instrumental variables). Instead, the assumption must be justified using theory.46 In this case, we argue 
that regional patterns in treatment assignment would be unrelated to an individual’s medication adherence 
except through the treatment patients actually receive. Medication adherence is an individual behavior, 
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and potential area-based predictors for its use are already being controlled for (health literacy, ADI, 
rurality, and regional medical supply). Therefore, we expect the geographic variation in treatment 
assignment to meet the exclusion restriction. In the limitations section, we note a potential violation of the 
exclusion restriction that we were unable to address in the model.  
4.3.4. Sensitivity Analyses 
 Sensitivity analyses were performed to assess the possibility of interaction effects between health 
literacy and the treatment to which patients were assigned. The interactions could not be included directly 
because the IV specification was exactly identified, and adding additional interaction terms with the 
endogenous variable (treatment assignment) would have made the model under-identified. Instead, the 
relationship was assessed by conducting stratified analyses that limited the analysis to subsets of the data. 
The analyses were run separately for the lowest health literacy quartile and the highest health literacy 
quartile.  
4.4. Results 
4.4.1. Sample Characteristics 
 Table 4.1. shows descriptive statistics for the 17,516 patients included in the sample broken out 
by treatment alternative. About two-thirds of the sample were assigned to medication only. Only 22 
percent received PCI and 10 percent received CABG. The percentage of patients that were adherent (PDC 
> 80%) ranged from 75 to 80 percent in the first six-month period and from 63 to 68 percent in the second 
six-month period. Patients who received medication only were more likely to be living in a low health 
literacy area, male, a racial/ethnic minority, and older. Descriptive statistics stratified by health literacy 
level appear in Appendix Table 17. The health literacy measure and ADI measure were moderately 
correlated (𝜌 = 0.315). 
4.4.2. Approach One: Probit Regression 
 The results for the first approach that used the dichotomous health literacy variable appear in 
Table 4.2. In the first specification without ADI and rural status (column M1), living in a low health 
literacy area relative to a high health literacy area was associated with a decrease in the percentage of 
 73 
adherent patients (-2.1 percentage points). This marginal effect was not statistically significant (p=0.07). 
Adding ADI and rural status slightly attenuated the marginal effect for health literacy (Column M2). For 
the quartile specifications (Appendix Table 18), living in the lowest health literacy quartile relative to the 
highest quartile was associated with a significant decrease (-2.6 percentage points); the magnitude 
increased to -3.1 percentage points after adding ADI and rural status. The marginal effects for all other 
quartiles relative to highest quartile were not statistically significant. The marginal effects for PCI and 
CABG were negative and generally consistent across all specifications.  
4.4.3. Approach Two: Probit Regression with IPTW 
 The results for second approach (Table 4.2., columns M3 and M4) were largely consistent with 
the first approach. The magnitude of the marginal effect on adherence for living in a low health literacy 
area was similar (-2.1 percentage points in the specification without rural and ADI), although this result 
was not statistically significant due to larger standard errors. The results were also consistent in the 
models that used the health literacy quartiles (Appendix Table 18). The marginal effects for the lowest 
health literacy quartile relative to the highest quartile increased in magnitude (to -3.2 percentage points 
from -2.6 percentage points). The marginal effects for PCI and CABG were similar to the first approach 
in magnitude and direction.  
4.4.4. Approach Three: 2SRI 
 The results for the third approach (Table 4.2., columns M5 and M6) were similar for health 
literacy. Living in a low health literacy area was associated with a decrease in adherence ( -1.4 percentage 
points for the model that did not control for ADI and rural status). This marginal effect was in the same 
direction as in the models that did not control for selection, but the marginal effect was smaller in 
magnitude and remained non-statistically significant. In the quartile specification for health literacy 
(Appendix Table 18), the marginal effect for the lowest quartile relative to the highest quartile was also 
smaller, but remained statistically significant. Figure 4.4 illustrates the relative consistency for the health 
literacy marginal effects across the different estimation methods and specifications. The marginal effect 
for receiving PCI and CABG differed considerably compared to the first two estimation methods. The 
 74 
marginal effect for receiving PCI was in the same direction as in the models that did not control for 
selection, but the magnitude was larger. The marginal effects for CABG shifted from negative to positive 
and very large in magnitude. The standard errors also increased considerably for PCI and CABG, which is 
often the case for IV analysis.  
4.4.5. Sensitivity Analysis 
 The results from the sensitivity analysis that assessed possible interactions between health literacy 
and treatment assignment appear in Table 4.3. The standard errors were large because the estimation 
method was 2SRI and the sample size was smaller. The marginal effects for CABG relative to medication 
only were similar for the lowest (19.2 percentage points) and highest (15.8 percentage points) quartiles. 
The marginal effects for PCI were more dissimilar. The marginal effect for the lowest quartile was -10.4 
percentage points compared to -2.7 percentage points for the highest quartile. However, this difference 
was not statistically significant due to the large standard errors. The results of the sensitivity analysis 
support a potential interaction effect between health literacy and receiving PCI.  
4.5. Discussion 
4.5.1. Summary 
 This study provided a thorough analysis of health literacy as a predictor for poor medication 
adherence using advanced methods to account for potential selection into treatment. When considering a 
dichotomous area-based health literacy measure, living in communities with low health literacy was not 
statistically significantly associated with adherence. The estimated marginal effect decreased in 
magnitude after including additional controls for area characteristics that may be related to literacy (i.e., 
ADI and rural status) or when alternative estimation methods were used. In the quartile specification for 
health literacy, living in areas of the lowest quartile relative to the highest quartile was associated with a 
significant decrease in adherence and this result was robust to additional controls and estimation methods. 
The marginal effects for PCI and CABG differed in the models that controlled for selection compared to 
the models that did not control for selection. These findings support the hypothesis that there was 
selection into treatment. The marginal effects for health literacy were not sensitive to whether the model 
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controlled for selection into treatment. The results provided limited evidence that area-based health 
literacy was a predictor for poor adherence.  
4.5.2. Possible Mechanisms and Implications 
 To our knowledge, this analysis is among one of the first to assess the relationship of health 
literacy and medication adherence using a large claims database and an area-based measure for health 
literacy. Prior systematic reviews examining the relationship between health literacy and medication 
adherence have either found inconsistent evidence4,9 or a small effect.10 The findings in the analysis 
provided only limited evidence for a relationship between area-based health literacy and medication 
adherence.  
It is unclear whether the area-based health literacy measure would be helpful for informing 
interventions to improve medication adherence. Previous research has documented successful 
interventions to improve adherence for cardiovascular-related diseases including informational mailings,47 
telephone follow-up,48 and pharmacist-led interventions.49 Given the limited nature of the findings 
presented in the current study and the small magnitude of the marginal effects, area-based health literacy 
does not appear to be a strong predictor for medication adherence for patients with SAP. More research is 
necessary to design interventions that promote safe medication use among patients with low or high 
health literacy skills.  
4.5.3. Limitations 
This analysis had several important limitations. First, claims data enable a large sample size but 
do not allow calculation of an individual measure of health literacy. The area-based measure has been 
validated in prior research,7,21 but individual assessments such as the REALM50 or TOFLHA8 would 
probably have estimated individual health literacy with less error. Second, low health literacy is 
associated with low socioeconomic status. As such, the results may be explained by low socioeconomic 
status instead of low health literacy. We included the ADI to see the effect of also controlling for area-
based socioeconomic status; high correlation between ADI and area-based health literacy may have 
resulted in the lack of statistically significant differences in adherence in relation to low versus high area 
 76 
health literacy. The claims data also precluded use of an individual measure of socioeconomic status. 
Third, there have recently been concerns about 2SRI producing biased results.51 Because of this concern, 
we did not focus on interpreting the marginal effects for PCI and CABG, which varied widely when using 
the 2SRI estimation method. Fourth, we had to make the assumption that the IVs met the exclusion 
restriction. While we believe that the regional treatment patterns were not associated with individual 
medication adherence except through being more likely to receive CABG or PCI, we could not directly 
assess this assumption. The assumption could be violated if regional treatment patterns were associated 
with efforts to encourage adherence in those regions. For example, regions that have higher utilization of 
medication only may be better at promoting medication adherence among their patients. Evidence 
supports such regional specialization in the treatment for myocardial infarctions.52 Fifth, we were unable 
to directly observe symptoms or angina severity using the claims. We did control for co-morbidities using 
the Deyo Charlson co-morbidity index as well as diabetes status since diabetes affects the treatment for 
SAP.53 Sixth, we were only able to observe medication claims and were unable to determine if patients 
were actually taking the medications. It is possible that actual adherence would be lower if we were able 
to observe whether patients actually consumed all pills for which they had claims. Seventh, the adherence 
measure included medication use on days before patients received PCI or CABG. The reason for this 
issue was that the period over which adherence was measured started at the date of first diagnosis. The 
start date of the adherence period could not have been the date of the first procedure since there would be 
no relevant date for patients that received medication only. In contrast, patients were categorized to PCI 
or CABG based on whether they received the procedure at any point during the follow-up period. Most 
patients received (about 70%) the procedure within the first 60 days following diagnosis, so most of the 
days occurred after the procedure. However, it is possible the results would be different if the analysis 
only included days following the procedure.   
 77 
4.5.4. Conclusions 
In summary, we found limited evidence for a small relationship between living in low health 
literacy communities and low medication adherence. We also found evidence for selection into treatment. 
Future research using individual assessments of health literacy and measures of symptoms and angina 
severity could be insightful if such information becomes available in a survey with sufficient sample size. 
Future research could also extend this analysis to evaluate health outcomes for these patients following 





Table 4.1. Descriptive Statistics by Treatment Category 







Adherent (PDC>80%) First Six 
Months Following Diagnosis 
Adherent 9,457 (79.5%) 3,069 (78.2%) 1,262 (74.7%) 
Non-Adherent 2,445 (20.5%) 855 (21.8%) 428 (25.3%) 
Adherent (PDC>80%) Second Six 
Months Following Diagnosis 
Adherent 8,126 (68.3%) 2,547 (64.9%) 1,058 (62.6%) 
Non-Adherent 3,776 (31.7%) 1,377 (35.1%) 632 (37.4%) 
Health Literacy 
Low Health 
Literacy Area 10,474 (88.0%) 3,573 (91.1%) 1,579 (93.4%) 
 
High Health 
Literacy Area 1,428 (12.0%) 351 (8.9%) 111 (6.6%) 
Sex 
Male 7,658 (64.3%) 1,824 (46.5%) 543 (32.1%) 
Female 4,244 (35.7%) 2,100 (53.5%) 1,147 (67.9%) 
Age 
65-70 2,878 (24.2%) 1,231 (31.4%) 530 (31.4%) 
70-75 2,273 (19.1%) 1,076 (27.4%) 506 (29.9%) 
75-80 2,198 (18.5%) 805 (20.5%) 355 (21.0%) 
80+ 4,553 (38.3%) 812 (20.7%) 299 (17.7%) 
RTI Race 
White 9,665 (81.2%) 3,384 (86.2%) 1,470 (87.0%) 
Black 1,094 (9.2%) 227 (5.8%)  59 (3.5%) 
Hispanic 657 (5.5%) 202 (5.1%)  96 (5.7%) 
Other 486 (4.1%) 111 (2.8%)  65 (3.8%) 
Diabetes 
No 7,389 (62.1%) 2,135 (54.4%) 858 (50.8%) 
Yes 4,513 (37.9%) 1,789 (45.6%) 832 (49.2%) 
Charlson Comorbidity Index 
0 7,618 (64.0%) 2,660 (67.8%) 1,140 (67.5%) 
1 2,386 (20.0%) 768 (19.6%) 321 (19.0%) 
2 1,095 (9.2%) 334 (8.5%) 159 (9.4%) 
3 507 (4.3%) 109 (2.8%) 52 (3.1%) 
4+ 296 (2.5%) 53 (1.4%) 18 (1.1%) 
Year 
2007 3,384 (28.4%) 909 (23.2%) 410 (24.3%) 
2008 2,140 (18.0%) 718 (18.3%) 305 (18.0%) 
2009 1,463 (12.3%) 578 (14.7%) 245 (14.5%) 
2010 1,132 (9.5%) 470 (12.0%) 201 (11.9%) 
2011 1,073 (9.0%) 409 (10.4%) 181 (10.7%) 
2012 1,104 (9.3%) 364 (9.3%) 161 (9.5%) 
2013 1,606 (13.5%) 476 (12.1%) 187 (11.1%) 
Area Deprivation Index Category 
Low Deprivation 10,179 (85.5%) 3,379 (86.1%) 1,490 (88.2%) 
High Deprivation 1,723 (14.5%) 545 (13.9%) 200 (11.8%) 
Rural Status 
Urban 8,986 (75.5%) 2,939 (74.9%) 1,273 (75.3%) 
Rural 2,916 (24.5%) 985 (25.1%) 417 (24.7%) 
Continuous Variables   Mean (SD) Mean (SD) Mean (SD) 
Cardiologists per 10K 0.68 (0.60) 0.68 (0.61) 0.66 (0.55) 
PCPs per 10K 7.23 (2.88) 7.13 (2.86) 7.10 (2.72) 
Beds per 10K 34.12 (27.03) 34.08 (24.60) 33.18 (29.57) 
Full Dual Eligible*  22.4% (40.8%) 11.1% (30.7%) 9.2% (28.1%) 
Partial Dual Eligible* 6.9% (24.4%) 5.4% (21.7%) 4.8% (20.4%) 
Receives Low Income Subsidy* 34.5% (47.1%) 21.0% (40.5%) 18.3% (38.3%) 
Area-Level Measure of Pct. Receiving PCI 21.6% (7.0%) 23.3% (7.2%) 22.5% (6.9%) 
Area-Level Measure of Pct. Receiving CABG 9.2% (4.3%) 9.4% (4.3%) 9.8% (4.2%) 
*Full dual eligible, partial dual eligible, and receives Low Income Subsidy are measured as the percentage of months that 
beneficiaries meet the criteria in the year following the index date. Note: CABG stands for coronary artery bypass grafting, PCI 





Table 4.2. Regression Output Using Binary Health Literacy Variable 
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*** p<0.001, ** p<0.01, * p<0.05 
Note: ME stands for marginal effect, SE stands for standard error, IPTW stands for inverse probability of treatment weighting, 2SRI stands for two-stage residual inclusion, CABG 
stands for coronary artery bypass grafting, PCI stands for percutaneous coronary intervention, ADI stands for area deprivation index, PCPs stands for primary care physicians. 
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Table 4.3. Sensitivity Analysis Stratified by Health Literacy Level 






 ME (SE) ME (SE) 
Medication Only Reference 
CABG  19.21% (14.50%) 15.80%* (13.16%) 
PCI -10.43% (17.43%) -2.73%* (13.27%) 
*** p<0.001, ** p<0.01, * p<0.05 







Figure 4.1. Sample Flow Diagram 
 
 
All Beneficiaries 2007-2014 
(N=5,558,582)
Beneficiaries Meeting Diagnostic 
Criteria (N=496,526)
Beneficiaries Meeting Medication 
Criteria (N=151,464)
No Prior Treatment (N=148,951)
Beneficiaries Without Excluding 
Diagnosis (N=75,071)
12 Months Prior and 12 Months Post 
FFS Coverage (N=50,001)
12 Months Post Part D Coverage 
(N=47,632)
Beneficiaries Merged to HL Measure 
(N=17,516)
Not meeting diagnosis criteria: 1) 2 diagnoses for stable angina; or 2) 
2 diagnoses for coronary artery disease and 2 diagnoses for chest 
pain. (N=5,062,056) 
Beneficiaries w/o at least one claim for nitrates in the ‘Medication 
Only’ (N=316,937) or one claim for nitrates, beta blockers, calcium 
channel blockers, or ranolazine in the PCI or CABG groups. (N=28,125)
Beneficiaries with prior PCI or CABG (N=2,513)
Beneficiaries with unstable angina (N=20,761), myocardial infarction 
(N=19,958), or both (N=33,161) prior to index date
Beneficiaries without 12 months prior FFS (N=16,721), without 12 
months post FFS (N=4,003), and without 12 months prior FFS or 12 
months post FFS (N=4,346)
Beneficiaries without 12 months post Part D coverage (N=2,369)
Part D Claims 2007-2014
Beneficiary Summary File 2006-2014
Procedural Codes from MedPAR, 
Carrier, and Outpatient 2006-2014
Diagnosis Codes from MedPAR, 
Carrier, and Outpatient 2007-2014
ExclusionsData Source Step
Area-Based Health Literacy Measure 
Merged to 9-digit ZIP
Beneficiaries that did not merge to health literacy measure 
(N=30,116)
Diagnosis Codes from MedPAR, 
Carrier, and Outpatient 2007-2014
Beneficiary Summary File 2006-2014
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Figure 4.2. Propensity Score Density Plot for Receiving Medication Only  
 
 
Figure 4.3. Propensity Score Density Plot for Receiving PCI  
 
 
Figure 4.4. Propensity Score Density Plot for Receiving CABG  
 
Note: PS stands for propensity score, PCI stands for percutaneous coronary intervention, CABG stands for coronary 
artery bypass grafting surgery.   
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Figure 4.5. Marginal Effects for Health Literacy 
 
Note: IPTW stands for inverse probability of treatment weighting, 2SRI stands for two-stage residual inclusion, HL 
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CHAPTER 5. CONCLUSIONS 
5.1. Summary 
 The main objective of this dissertation was to assess the relationship of health literacy with key 
patient behaviors for the treatment of SAP. To our knowledge, the Chapter 2 analysis was first study to 
assess the relationship between area-based health literacy and treatment assignment for patients with SAP. 
The Chapter 3 analysis was the first study to characterize patient-clinician conversations to discuss 
treatment alternatives for SAP and assess health literacy as a potential barrier to communication in these 
conversations. The Chapter 4 analysis was the first study to assess the relationship between health literacy 
and medication adherence using an area-based measure for health literacy. The Chapter 2 and Chapter 4 
analyses leveraged a large, national claims database to ensure a large sample size that was representative 
of elderly Medicare beneficiaries nationwide. The Chapter 3 analysis used a unique data source of 
recorded conversations between patients and clinicians to make sure the findings reflected actual clinical 
practice. The findings from these analyses help to inform potential interventions to improve patient-
clinician discussions and medication adherence, particularly for patients with low health literacy.  
5.1.1. Health Literacy and Treatment Assignment 
 The Chapter 2 analysis used multinomial logistic regression to assess the relationship between 
area-based health literacy and treatment assignment into medication only, PCI, or CABG. The data source 
was a 20 percent sample of Medicare claims for beneficiaries aged 65 years and older who had 
simultaneous enrollment in Medicare Parts A, B, and D. The study found that living in a low health 
literacy area relative to a high health literacy area was associated with a significant increase in the 
percentage of patients receiving medication only (2.9 percentage points) and a significant decrease in the 
percentage of patients receiving CABG (-3.0 percentage points). After adding controls for ADI and rural 
status, the marginal effect for living in a low health literacy area with respect to medication only become 
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non-significant and the marginal effect with respect to CABG remained significant. The results for the 
quartile specification of health literacy differed somewhat. Living in the lowest quartile with respect to 
the highest quartile was still associated with significantly greater use of medication only. However, living 
in the lowest health literacy quartile was associated with significantly lower use of PCI but not CABG. In 
summary, these findings suggest that living in a low health literacy area was associated with greater use 
of the least invasive treatment alternative (medication only) and lower use of the two more invasive 
treatment alternatives (CABG and PCI).  
 The results supported the hypothesis that patients living in low health literacy communities may 
have had greater difficulty accessing PCI and CABG. Previous research has identified low health literacy 
as a predictor for reduced access to care.1 The marginal effects for variables related to established 
predictors for worse access to care (rural status,2 minority status3, and low-income4) were generally in the 
same direction as the marginal effects for living in a low health literacy area. Typically, low access to care 
for patients is considered a problem since poor access to care is generally associated with worse health 
outcomes.5 However, in the context of treatment of SAP, where outcomes are equivalent across more and 
less invasive treatment options for most patients, reduced access to PCI and CABG may actually be 
beneficial to patients. The study results contradicted our hypothesis that patients living in low health 
literacy areas would be more likely to receive more aggressive care, which would potentially be related to 
common misconceptions about the value of more invasive treatment for SAP.6-8 Contrary to this 
hypothesis, patients living in low health literacy areas were actually less likely to receive PCI or CABG.  
5.1.2. Characterization of Treatment Planning Discussions 
 The Chapter 3 analysis used a descriptive approach to characterize recorded patient-clinician 
interactions during treatment planning discussion for SAP. The analysis also assessed the potential role of 
health literacy as a barrier to communication. Health literacy was measured using a validated screening 
question.9,10 The study found that patients tended to ask few questions about the clinical aspects of 
treatment alternatives (an average of one per discussion). Patients were more likely to ask questions about 
the logistics of treatment such as how long a procedure would take. Clinicians appeared to have similar 
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approaches to communication for their patients. Some clinicians had consistently low shared decision-
making and some had consistently high shared-decision making across multiple patients. This finding 
may be explained by either distinct clinician approaches to shared decision-making or the setting for the 
conversation (general cardiology clinic or cardiac catheterization lab). Finally, health literacy was 
associated with significantly greater decisional conflict, but not worse performance on the knowledge 
assessment or fewer questions asked during the conversations.  
 The results provide some support for health literacy as a potential barrier to communication, but 
the evidence was exploratory given the small sample size. Low health literacy was associated with greater 
decisional conflict following discussions. Low health literacy was not associated with worse performance 
on the knowledge assessment that tested patient understanding of the treatment alternatives. Low health 
literacy was also not associated with asking fewer questions or expressing fewer preferences during the 
conversations. The lack of statistical significance was partially due to the small sample size and small 
share of patients that were categorized as having low health literacy.  
5.1.3. Health Literacy and Medication Adherence 
 The Chapter 4 analysis used probit regression, inverse probability of treatment weighting, and 
two-stage residual inclusion to assess the relationship between health literacy and mediation adherence to 
anti-anginal medications. The analysis also used the same 20 percent Medicare claims sample that was 
used in the Chapter 2 analysis. The study found that living in a low health literacy area was not associated 
with significantly worse adherence when using the dichotomous specification of health literacy. However, 
living in the lowest health literacy quartile relative to the highest quartile was associated with a significant 
decrease in medication adherence (-2.3 percentage points to -4.6 percentage points depending on the 
estimation method). While we found evidence that suggests there may be selection into treatment 
(Medication Only, PCI, or CABG), the results for health literacy appeared consistent across the different 
estimation methods. These results were consistent with the findings from previous systematic reviews that 
found inconclusive evidence1,11 or only a small significant association between health literacy and 
medication adherence.12  
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5.2. Implications for Policy  
 The goal of this dissertation was to inform potential interventions that are sensitive to health 
literacy. The aims analyze treatment assignment and medication adherence, which involve patient and 
provider behaviors that may be associated with the patient’s health literacy. Interventions exist to help 
ensure treatment assignment incorporates patient preferences (e.g., shared decision-making tools) and 
improve medication adherence (e.g., medication reminders). However, the gaps in the literature with 
respect to health literacy make it difficult to determine whether health literacy should be considered when 
developing these interventions. The dissertation research helps to address these gaps and inform the 
design for such interventions. 
 The results from Chapters 2 and 3 provided mixed evidence on the relationship for health literacy 
with treatment assignment and treatment planning discussions. Living in a low health literacy area was 
not associated with being more likely to receive more invasive treatment. For the treatment of SAP, the 
main concern has been that misconceptions about the value of PCI relative to medication only lead to 
lower than optimal use of medication only.13,14 In addition, there were not statistically significant 
differences in the proportion of knowledge questions answered correctly by health literacy category. This 
finding also contradicts the hypothesis that misconceptions about the relative benefits of treatment 
alternatives are more prevalent among patients with low health literacy. Any educational interventions 
should be made available for all patients regardless of their health literacy status. Low health literacy was 
found to be significantly associated with greater decisional conflict. This finding provided some support 
for a need to ensure that patient-clinician communication is suitable for patients with limited health 
literacy skills. However, the limitations of the analysis (small sample size and single institution) means 
that more research confirming this result in other contexts may be needed before basing interventions 
around the finding. It is also possible that the greater decisional conflict may be associated with patients 
regretting the treatment that the patient selected with their clinician. In previous research, decisional 
conflict and decisional regret appear to be affected by similar factors15,16 and it possible that higher 
decisional conflict may be associated with patients have greater decisional regret. This possibility would 
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also need to be confirmed in additional research as the data for the Chapter 3 analysis did not include a 
measure of decisional regret.     
 The results from Chapter 2 suggested that patients with low health literacy had lower access to 
more interventional treatments. Although this lower receipt of interventional therapies may prove 
beneficial in the context of SAP, health systems may want to consider providing additional resources to 
communities with low area-based health literacy to improve access to care for conditions in which better 
access is tied to improved health outcomes. Having better access to care has been linked with better health 
outcomes for many conditions.5 However, the relationship between area-based health literacy and access 
to care may be specific to treatment for SAP. As such, more research confirming these findings for other 
conditions are needed before designing interventions. 
 The results from Chapter 4 provided limited evidence on a relationship between area-based health 
literacy and medication adherence for patients with SAP. Across all estimation methods, living in a low 
health literacy area was not significantly associated with medication adherence. However, in the quartile 
specification living in the lowest health literacy quartile relative to the highest quartile was associated 
with worse medication adherence across all estimation methods. The magnitude of the marginal effect for 
this result ranged from small (-2.3 percentage points) to moderate (4.6 percentage points). Given that the 
results were sensitive the how the health literacy measure was specified (quartile or dichotomous) and the 
magnitude of the association was not large, the results suggest that area-level measures of health literacy 
are not an important factor in medication adherence. The magnitude of the marginal effects may have 
been stronger if an individual-level health literacy measure was available since there would be less error 
in categorizing individuals as low or high health literacy (assuming the area-based health literacy measure 
is being used as a proxy for individual health literacy). Further research would be necessary to confirm 
this possibility.   
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5.3. Limitations 
 This dissertation has several limitations that affect the interpretation of the results. First, the 
analyses for Chapters 2 and 4 used an area-based measure for health literacy and socioeconomic status. 
The area-based measure for literacy has been previously validated and was found to have fair agreement 
with several individual measures for health literacy (κ ranging from 0.38 to 0.40). Nevertheless, the use of 
the area-based measure was associated with greater error than individual measures for health literacy.17 A 
particular concern is the ecological fallacy: The associations observed for patients living in areas with low 
health literacy may not hold for individuals within these communities who have low health literacy. A 
way to address the concerns about the ecological fallacy is to interpret the results as measuring 
community health literacy measures and not as a proxy for individual health literacy. Similar concerns 
exist for the ADI since it is also an area-based measure for socioeconomic status. The ADI can also be 
interpreted as measuring community SES to address concerns about the ecological fallacy. While 
interpreting the area-based measures in terms of community health literacy and SES partially address 
concerns about the ecological fallacy, the studies would have been stronger if we had been able to identify 
a data source with a large sample that also included individual measures for health literacy and SES. We 
initially attempted to use survey data linked with claims data from the Health and Retirement Study 
(HRS) that included individual measures for health literacy and SES. However, the sample size was too 
small to perform the analyses. We also assessed the Medicare Current Beneficiary Survey since these data 
would have measures beyond claims, but the sample size was similarly too small to be useful for analysis. 
 Second, many relevant clinical variables that affect treatment assignment for patients with SAP 
were not available. The claims did not have information on disease severity such as the extent of blockage 
and whether the patient had left main coronary artery disease. The claims also lacked information about 
anatomic variants in the coronary arteries. These factors change the relative tradeoffs for medication only, 
PCI, and CABG.18 The claims data also lacked detailed information on the status of patient’s symptoms. 
It is possible that patients received PCI or CABG in response to not receiving sufficient symptom relief 
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from medication only. The lack of symptom information also prevented the analysis of whether patients 
reduced adherence to anti-anginals in response to improvements in symptom status.  
 Third, there were methodological concerns for the Chapters 2 and 4 analyses. In Chapter 2, 
multinomial logistic regression was used to model treatment assignment to medication only, PCI, or 
CABG. However, the independence of irrelevant alternatives (IIA) assumption was violated.19 Violations 
of this assumption can lead to biased coefficients and marginal effects. In practice, violations of this 
assumption are often ignored. We attempted to assess this assumption by collapsing the three-category 
treatment variable to a dichotomous variable of medication only vs. PCI or CABG. The results were 
largely consistent with the analysis using the three-category variable. A better approach would have been 
to run a nested logit or multinomial probit with a more flexible error structure. These options could not be 
performed because we lacked alternative-specific variables in the data. In Chapter 4, we used an 
instrumental variable approach with 2SRI. For IV analyses that are exactly identified, the exclusion 
restriction assumption cannot be tested directly and can only be defended by theory. We noted a potential 
violation of this assumption in the discussion section of Chapter 4. In addition, there have recently been 
concerns about 2SRI producing biased results.20 Because of this concern, we did not focus on interpreting 
the marginal effects for PCI and CABG, which varied widely when using the 2SRI estimation method.  
 Fourth, the Chapter 3 analysis used a small sample that may not be generalizable to the broader 
population. The full sample (N=118) and recording sample (N=53) were relatively small and an even 
smaller share of these samples were individuals categorized as having low health literacy via self-report 
(22/118 for the full sample and 10/53 for the recording sample). The small sample size meant that the 
statistical power for the analyses was relatively low. In addition, only one person who was a racial or 
ethnic minority was included in the sample and the conversations took place at the Mayo Clinic, which is 
a premier health system. As such, these results may not be generalizable to populations that include racial 
or ethnic minorities and to health systems that operate differently or draw from a different patient 
population than the Mayo Clinic. Limitations on generalizability and sample size are common for 
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qualitative research since it is usually not feasible to conduct such analyses using large, representative 
samples.   
 Fifth, the health literacy measure for the Chapter 3 analysis relied on patient self-report. In the 
analysis, health literacy was assessed using a validated screening question: “How confident are you filling 
out healthcare forms by yourself?”9,10 This screening question had good agreement when compared with 
instruments for measuring health literacy (REALM21 and TOFHLA22)9,10 Nevertheless, there is more error 
in measuring health literacy with this screening question than with the instruments.9,10  
 Sixth, the area-based measure could only be merged with approximately 40 percent of the cases 
identified in the claims. This issue was due to the inability to geocode many of the 9-digit ZIP codes in 
the claims data with respect to the census block-group. We investigated whether the individuals who 
merged were similar to individuals who were not merged. We found no systematic differences in terms of 
demographic characteristics. However, it is possible that these groups differed on unobservable 
characteristics.  
5.4. Future Research Directions 
 As the number of individuals with low health literacy grows in the coming years,23 it will become 
increasingly important to understand how health literacy affects key patient behaviors. This dissertation 
research contributes to the evidence base on this issue and lays the groundwork for further research.  
 The dissertation provided additional evidence on the viability of using an area-based measure for 
health literacy. We found that the area-based health literacy measure could be successfully merged with a 
Medicare claims sample. The area-based health literacy measure could be applied to the treatment for 
other diseases such as diabetes or cancer. In particular, analyses could examine whether living in a low 
health literacy area is associated with worse access to care for other conditions. The Chapter 2 results 
suggested that there was a relationship between living in a low health literacy area and worse access to 
care. While lower access to care may be beneficial for the treatment of SAP, for other conditions poor 
access to care is a predictor of worse health outcomes.5 For such conditions, it may be valuable to 
understand whether living in a low health literacy areas is a barrier to access. This research could inform 
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interventions to improve access to care for these conditions among patients living in a low health literacy 
community. 
The Chapter 4 analysis could be re-analyzed using alternative estimation methods and ways of 
specifying the period over which adherence is measured to address limitations. As noted, there are 
concerns about the use of 2SRI.20 One way to address these concerns would be to use alternative residual 
specifications as sensitivity analyses. The Chapter 4 analysis used only the raw residuals, but other 
residual specification can be evaluated. These approaches include the standardized residuals, deviance 
residuals, Anscombe residuals, and generalized residuals.20 Appendix Tables 19 and 20 shows the results 
for two of these residual specifications. The results for both dichotomous and quartile health literacy were 
similar across the different residual specifications. The future work will extend to include the other 
residual specifications. Another concern was that the period over which adherence was measured included 
days before patients received PCI or CABG. The reason for this issue was that the period started on the 
date of the first diagnosis for SAP and treatment group was defined based on whether the patient received 
either PCI or CABG at any point during the period. An alternative approach would be to exclude the first 
six months after diagnosis from the adherence period and define treatment groups based on whether the 
patient received PCI or CABG within the first six months. This approach would ensure that the adherence 
measure does not include days before the patient received a procedure. Patients who received PCI or 
CABG after the first six months and before the end of the adherence period would be excluded from the 
analysis. Appendix Figures 1 and 2 show that most patients received PCI or CABG within the first six 
months following diagnosis. As such, only a small proportion of patients who received PCI or CABG 
would need to be dropped. 
 The Chapter 4 analysis could be extended to examine other medications for SAP or medications 
for other conditions. The analysis only examined medication adherence for anti-anginal medications. The 
analysis could also include other medications that patients take for coronary artery disease including anti-
platelet therapy, ACE inhibitors, and statins. An advantage of examining these medications is that they 
impact health outcomes, whereas anti-anginal medications are primarily used for symptom relief.18 As 
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such, the behavioral response may be different for these medications. This analysis could also be applied 
to medication adherence for other chronic conditions such as hypertension and diabetes.  
 Lastly, the Chapter 4 analytical approach could be applied to outcomes for SAP other than 
medication adherence. In particular, the analyses could examine the relationship of area-based health 
literacy and treatment assignment with health outcomes after controlling for selection into treatment. 
Important health outcomes for these patients that are available in the claims data include myocardial 
infarction, cardiovascular death, and emergency room visits or inpatient admissions related to coronary 
artery disease.  
5.5. Conclusion 
 In summary, this dissertation provided evidence on how health literacy is related to treatment 
assignment, discussion quality, and medication adherence. In this dissertation, we found that: 1) living in 
low health literacy areas was associated with lower utilization of more invasive treatment (PCI and 
CABG), 2) low health literacy may act as a potential barrier to patient-clinician communication, and 3) 
living in low health literacy areas was associated with worse medication adherence but the evidence was 
limited and depended on how the health literacy variable was specified. These findings have implications 
for the importance of considering health literacy in analyzing treatment assignment and medication 
adherence. The results also support a broad need for interventions to improve communication to make it 
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APPENDIX 1. APPENDIX TABLES FOR CHAPTER 2 
Appendix Table 1. Diagnostic Algorithms for Identifying Stable Angina Pectoris  
Algorithm Diagnostic Criteria Medication Criteria 
1 • 2 claims with diagnoses for stable 
angina pectoris  
• 2 claims for nitrates for medical therapy  
• No claims for nitrates required for PCI or 
CABG 
2 • 2 claims with diagnoses for 
coronary artery disease 
• 2 claims with diagnoses for chest 
pain 
• 2 claims for nitrates for medical therapy  
• No claims for nitrates required for PCI or 
CABG 
Adapted from Kempf et al. 2011. Note that medication use was not required for patients receiving PCI or 
CABG because receiving a procedure was considered sufficient evidence that the patient had stable 
angina pectoris.  
 
Appendix Table 2. International Classification of Diseases, Ninth Revision 4 
Diagnosis  ICD-9 Codes 
Stable angina pectoris 413.0, 413.1, 413.9 
Coronary artery disease 411.0, 411.1, 411.8, 411.81, 411.89, 414.00, 414.01, 
414.02, 414.03, 414.04, 414.05, 414.06, 414.07, 414.10, 
414.11, 414.12, 414.19, 414.2, 414.3, 414.8, 414.9, 
429.2, 429.6, 429.71, 429.79, 996.03, V45.81, V45.82 
Chest pain 786.51, 785.52, 786.59 
Myocardial infarction 410.0, 410.1, 410.2, 410.3, 410.4, 410.5, 410.6, 410.7, 
410.8, 410.00, 410.01, 410.02, 410.10, 410.11, 410.12, 
410.20, 410.21, 410.22, 410.30, 410.31, 410.32, 410.40, 
410.41, 410.42, 410.50, 410.51, 410.52, 410.60, 410.61, 
410.62, 410.70, 410.71, 410.72, 410.80, 410.81, 410.82, 
410.90, 410.91, 410.92, 412" 
 
Unstable angina pectoris 411.1 
Diabetes  249.01, 249.10, 249.11, 249.20, 249.21, 249.30, 249.31, 
249.40, 249.41, 249.50, 249.51, 249.60, 249.61, 249.70, 
249.71, 249.80, 249.81, 249.90, 249.91, 250.00, 250.01, 
250.02, 250.03, 250.10, 250.11, 250.12, 250.13, 250.21, 
250.22, 250.23, 250.30, 250.31, 250.32, 250.33, 250.40, 
250.41, 250.42, 250.43, 250.50, 250.51, 250.52, 250.53, 
250.60, 250.61, 250.62, 250.63, 250.71, 250.72, 250.73, 




Appendix Table 3. Procedural Codes  
Procedure Code Type Codes 
PCI CPT (pre 2013) 92980, 92981, 92982, 92983, 92984, 
92995, 92996 
CPT (post 2013) 92920, 92921, 92924, 92925, 92928, 
92929, 92933, 92934, 92937, 92938 
ICD-9 Procedure 00.66, 36.06, 36.01, 36.02, 36.05, 36.09 
DRG (pre 2008) 518, 555, 556, 557, 558 
DRG (post 2008) 246, 247, 248, 249, 250, 251 
CABG CPT 33510, 33511, 33512, 33513, 33514, 
33516, 33517, 33518, 33519, 33520, 
33521, 33522, 33523, 33530, 33533, 
33534, 33535, 33536 
ICD-9 Procedure 36.1, 36.10, 36.11, 36.12, 36.13, 36.14, 
36.15, 36.16, 36.17, 36.19 
DRG (pre 2008) 106, 547, 548, 549, 550 
 DRG (post 2008) 231, 232, 233, 234, 235, 236 
Note: CABG stands for coronary artery bypass graft surgery, CPT stands for current procedural 





Appendix Table 4. Descriptive Statistics by Health Literacy Quartile  
  






Q4 (High HL) 
N=3,732 
Variable Level Freq (Pct) Freq (Pct) Freq (Pct) Freq (Pct) 
Treatment Received 
Medical therapy 1,699 (56.0%) 2,284 (49.8%) 1,933 (47.3%) 1,589 (42.6%) 
CABG 397 (13.1%) 735 (16.0%) 669 (16.4%) 662 (17.7%) 
PCI 940 (31.0%) 1,563 (34.1%) 1,483 (36.3%) 1,481 (39.7%) 
Male 1,791 (59.0%) 2,548 (55.6%) 2,124 (52.0%) 1,760 (47.2%) 
Sex 
Female 1,245 (41.0%) 2,034 (44.4%) 1,961 (48.0%) 1,972 (52.8%) 
65-70 894 (29.4%) 1,210 (26.4%) 1,042 (25.5%) 926 (24.8%) 
Age 
70-75 655 (21.6%) 1,031 (22.5%) 911 (22.3%) 811 (21.7%) 
75-80 596 (19.6%) 882 (19.2%) 836 (20.5%) 734 (19.7%) 
80+ 891 (29.3%) 1,459 (31.8%) 1,296 (31.7%) 1,261 (33.8%) 
Male 1,468 (48.4%)  4,085 (89.2%) 3,826 (93.7%) 3,527 (94.5%) 
Sex 
Female 856 (28.2%) 216 (4.7%) 67 (1.6%)  44 (1.2%) 
White 537 (17.7%) 137 (3.0%) 92 (2.3%)  43 (1.2%) 
Black 175 (5.8%) 144 (3.1%) 100 (2.4%) 118 (3.2%) 
No 1,457 (48.0%) 2,589 (56.5%) 2,343 (57.4%) 2,312 (62.0%) 
Diabetes 
Yes 1,579 (52.0%) 1,993 (43.5%) 1,742 (42.6%) 1,420 (38.0%) 
0 1,797 (59.2%) 2,812 (61.4%) 2,636 (64.5%) 2,568 (68.8%) 
Charlson Comorbidity 
Index 
1 633 (20.8%) 1,000 (21.8%) 860 (21.1%) 704 (18.9%) 
2 357 (11.8%) 456 (10.0%) 352 (8.6%) 281 (7.5%) 
3 162 (5.3%) 185 (4.0%) 155 (3.8%) 119 (3.2%) 
4+  87 (2.9%) 129 (2.8%)  82 (2.0%)  60 (1.6%) 
2007 955 (31.5%) 1,306 (28.5%) 1,023 (25.0%) 879 (23.6%) 
Year 
2008 592 (19.5%) 845 (18.4%) 778 (19.0%) 612 (16.4%) 
2009 379 (12.5%) 593 (12.9%) 552 (13.5%) 521 (14.0%) 
2010 319 (10.5%) 474 (10.3%) 430 (10.5%) 428 (11.5%) 
2011 254 (8.4%) 423 (9.2%) 396 (9.7%) 377 (10.1%) 
2012 243 (8.0%) 429 (9.4%) 374 (9.2%) 387 (10.4%) 
2013 294 (9.7%) 512 (11.2%) 532 (13.0%) 528 (14.1%) 
Q1 (Low Depr.) 308 (10.5%) 595 (13.7%) 929 (23.6%) 2,131 (58.6%) 
ADI Quartiles 
Q2 512 (17.5%) 836 (19.3%) 1,285 (32.6%) 1,012 (27.8%) 
Q3 641 (21.9%) 1,500 (34.6%) 1,237 (31.4%) 394 (10.8%) 
Q4 (High Depr.) 1,465 (50.1%) 1,402 (32.4%) 491 (12.5%) 97 (2.7%) 
Urban 2,384 (78.5%) 2,698 (58.9%) 3,013 (73.8%)  3,407 (91.3%) 
Rural Status Rural 652 (21.5%) 1,884 (41.1%) 1,072 (26.2%) 325 (8.7%) 
Variable   Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Cardiologists per 10K 
Residents  
0.72 (0.54) 0.53 (0.52) 0.63 (0.57) 0.86 (0.68) 
PCPs per 10K 
Residents  
6.88 (2.56) 6.47 (2.73) 7.10 (2.76) 8.21 (2.94) 
Beds per 10K Residents  36.24 (25.57) 34.15 (30.59) 33.37 (23.83) 33.45 (23.38) 
Full Dual Eligible   37.1% (47.3%) 19.0% (38.4%) 12.0% (31.6%) 8.6% (27.4%) 
Partial Dual Eligible   10.0% (28.8%) 7.9% (25.9%) 5.7% (22.1%) 2.6% (15.3%) 
Low Income Subsidy   54.2% (49.4%) 32.3% (46.4%) 22.0% (41.0%) 13.6% (34.0%) 
Percent Receiving PCI   34.6% (9.3%) 35.3% (9.4%) 35.1% (9.9%) 35.3% (9.9%) 
Percent Receiving 
CABG   14.5% (5.5%) 15.0% (5.6%) 15.0% (5.8%) 15.1% (5.7%) 
*Full dual eligible, partial dual eligible, and receives Low Income Subsidy are measured as the percentage of months that 
beneficiaries meet the criteria in the year following the index date. 
Note: CABG stands for coronary artery bypass grafting, PCI stands for percutaneous coronary intervention 
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Appendix Table 5. Marginal Effects for Quartile Specification  
















Q1 (Low HL) 
13.38%*** 5.19%*** 3.57%* 4.98%*** 3.54%* 
(1.21%) (1.31%) (1.50%) (1.31%) (1.50%) 
Q2 
7.27%*** 3.62%*** 2.24% 3.64%*** 2.43%* 
(1.10%) (1.06%) (1.20%) (1.06%) (1.20%) 
Q3 
4.74%*** 3.21%** 2.04% 3.23%** 2.19%* 
(1.12%) (1.04%) (1.11%) (1.04%) (1.11%) 
Q4 (High HL) Reference 
Rural & ADI     ✓  ✓ 
Percent 
Receiving 
PCI & CABG 
    
 
✓ ✓ 
      
  




Q1 -8.72%*** -4.41%*** -3.38%* -4.25%** -3.37%* 
(Low HL) (1.16%) (1.33%) (1.53%) (1.33%) (1.53%) 
Q2 
-5.57%*** -3.43%** -2.81%* -3.43%** -2.99%* 
(1.06%) (1.08%) (1.22%) (1.08%) (1.22%) 
Q3 
-3.38%** -2.38%* -1.44% -2.42%* -1.60% 




Rural & ADI     ✓  ✓ 
Percent 
Receiving 
PCI & CABG 
    
 
✓ ✓ 
        






-4.66%*** -0.77% -0.19% -0.73% -0.17% 
  (0.87%) (1.04%) (1.18%) (1.04%) (1.18%) 
 Q2 -1.70%* -0.20% 0.57% -0.21% 0.56% 
  (0.83%) (0.83%) (0.93%) (0.82%) (0.93%) 
 Q3 -1.36% -0.82% -0.60% -0.82% -0.59% 





Rural & ADI     ✓  ✓ 
Percent 
Receiving 
PCI & CABG     
 ✓ ✓ 
Observations 15,435 15,435 14,835 15,435 14,835 
Standard errors in parentheses. *** p<0.001, ** p<0.01, * p<0.05.  
Note: ADI stands for area deprivation index. CABG stands for coronary artery bypass grafting, HL stands for health 
literacy, PCI stands for percutaneous coronary intervention. 
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Appendix Table 6. Full Model Marginal Effects for Multinomial Logistic Regression with Quartile 
Specification of Health Literacy Variable  
































Q1 (Low HL) 
13.38%*** 5.19%*** 3.57%* 4.98%*** 3.54%* 
(1.21%) (1.31%) (1.50%) (1.31%) (1.50%) 
Q2 
7.27%*** 3.62%*** 2.24% 3.64%*** 2.43%* 
(1.10%) (1.06%) (1.20%) (1.06%) (1.20%) 
Q3 
4.74%*** 3.21%** 2.04% 3.23%** 2.19%* 
(1.12%) (1.04%) (1.11%) (1.04%) (1.11%) 
Q4 (High HL) Reference 
Age Cubic 
Splines 
      





 -1.64% -1.16% -1.41% -1.04% 
 





 0.16% 0.24% 0.14% 0.21% 
 
 (0.21%) (0.21%) (0.21%) (0.21%) 
Beds per 10K 
Residents 
 
 0.02% 0.02% 0.02% 0.01% 
 




 6.03%*** 5.49%*** 6.00%*** 5.48%*** 
 




 15.34%*** 15.96%*** 15.04%*** 15.68%*** 
 




 4.00% 4.81%* 3.75% 4.54%* 
 




10.11%*** 10.48%*** 9.78%*** 10.12%*** 
 (1.61%) (1.65%) (1.61%) (1.64%) 
Hispanic  
-6.45%*** -6.45%*** -6.41%*** -6.45%*** 
 (1.77%) (1.80%) (1.77%) (1.80%) 
Other  
3.00% 3.90% 2.64% 3.47% 
 (2.16%) (2.20%) (2.16%) (2.20%) 
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 -12.34%*** -11.96%*** -12.28%*** -11.91%*** 
 
 (0.77%) (0.78%) (0.77%) (0.78%) 
Diabetes 
 
 -4.84%*** -5.27%*** -4.86%*** -5.28%*** 
 






-2.09%* -1.88%* -2.02%* -1.81% 
 (0.93%) (0.95%) (0.93%) (0.95%) 
2  
1.55% 1.42% 1.59% 1.50% 
 (1.30%) (1.32%) (1.30%) (1.32%) 
3  
6.42%*** 6.21%** 6.42%*** 6.21%** 
 (1.95%) (1.97%) (1.94%) (1.96%) 
4+  
14.15%*** 13.81%*** 14.10%*** 13.76%*** 




-2.72%* -2.72%* -1.28% -1.26% 
 (1.11%) (1.13%) (1.12%) (1.14%) 
2009  
-7.46%*** -7.00%*** -4.75%*** -4.29%*** 
 (1.23%) (1.25%) (1.27%) (1.29%) 
2010  
-8.03%*** -7.97%*** -4.60%*** -4.53%** 
 (1.32%) (1.35%) (1.39%) (1.42%) 
2011  
-5.74%*** -5.17%*** -2.51% -1.91% 
 (1.39%) (1.42%) (1.44%) (1.47%) 
2012  
-0.86% -0.96% 1.45% 1.37% 
 (1.41%) (1.43%) (1.42%) (1.45%) 
2013  
4.71%*** 4.88%*** 7.00%*** 7.18%*** 




     
 
     
Rural 
 
  2.70%*  2.38%* 
 

































ADI Quartiles Q1 (Low 
Deprivation 
Reference 
Q2   
2.00%  1.76% 
  (1.15%)  (1.15%) 
Q3   
3.04%*  2.67%* 
  (1.29%)  (1.29%) 
Q4 (High 
Deprivation) 
  2.19%  1.85% 





   -0.28%*** -0.28%*** 
 




   -0.36%*** -0.35%*** 
 




Q1 (Low HL) 
-8.72%*** -4.41%*** -3.38%* -4.25%** -3.37%* 
(1.16%) (1.33%) (1.53%) (1.33%) (1.53%) 
Q2 
-5.57%*** -3.43%** -2.81%* -3.43%** -2.99%* 
(1.06%) (1.08%) (1.22%) (1.08%) (1.22%) 
Q3 
-3.38%** -2.38%* -1.44% -2.42%* -1.60% 
(1.10%) (1.06%) (1.13%) (1.06%) (1.13%) 
Q4 (High HL) Reference 
Age Cubic 
Splines 
      





 1.61% 1.78% 1.39% 1.66% 
 





 -0.15% -0.23% -0.12% -0.18% 
 
 (0.21%) (0.22%) (0.21%) (0.22%) 
Beds per 10K 
Residents 
 
 -0.01% -0.01% -0.00% -0.00% 
 




 -4.24%* -3.93%* -4.20%* -3.90%* 
 




 -8.64%*** -9.22%*** -8.39%*** -9.00%*** 
 




 -3.21% -4.00% -2.90% -3.68% 
 

























Race White Reference 
Black  
-3.69%* -3.93%* -3.38%* -3.57%* 
 (1.61%) (1.64%) (1.61%) (1.64%) 
Hispanic  
2.19% 2.52% 2.16% 2.51% 
 (1.97%) (2.00%) (1.96%) (1.99%) 
Other  
-2.62% -2.99% -2.37% -2.67% 
 (2.21%) (2.23%) (2.21%) (2.23%) 
Female 
 
 3.30%*** 3.03%*** 3.23%*** 2.97%*** 
 
 (0.77%) (0.79%) (0.77%) (0.78%) 
Diabetes 
 
 1.34% 1.85%* 1.36% 1.85%* 
 






1.45% 1.53% 1.39% 1.47% 
 (0.96%) (0.98%) (0.96%) (0.98%) 
2  
-3.08%* -3.11%* -3.12%* -3.18%* 
 (1.32%) (1.34%) (1.32%) (1.34%) 
3  
-5.25%** -5.31%** -5.26%** -5.33%** 
 (1.93%) (1.96%) (1.93%) (1.95%) 
4+  
-8.59%*** -8.68%*** -8.58%*** -8.68%*** 




3.34%** 3.38%** 2.18% 2.22% 
 (1.13%) (1.15%) (1.16%) (1.18%) 
2009  
6.48%*** 6.45%*** 4.10%** 4.09%** 
 (1.27%) (1.29%) (1.31%) (1.34%) 
2010  
6.37%*** 6.00%*** 3.27%* 2.93%* 
 (1.37%) (1.40%) (1.43%) (1.45%) 
2011  
5.08%*** 4.84%*** 2.15% 1.92% 
 (1.42%) (1.45%) (1.47%) (1.49%) 
2012  1.41% 1.57% -0.65% -0.49% 
 (1.41%) (1.43%) (1.43%) (1.46%) 
2013  -1.04% -1.20% -3.03%* -3.18%* 
 (1.28%) (1.30%) (1.31%) (1.34%) 
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Rural 
 
  -0.79%  -0.46% 
 





Q2   
-1.12%  -0.86% 
  (1.17%)  (1.16%) 
Q3   
-2.33%  -1.94% 
  (1.31%)  (1.31%) 
Q4 (High 
Deprivation) 
  -1.28%  -1.00% 





   0.12% 0.12% 
 




   0.37%*** 0.36%*** 
 




Q1 (Low HL) -4.66%*** -0.77% -0.19% -0.73% -0.17% 
 (0.87%) (1.04%) (1.18%) (1.04%) (1.18%) 
Q2 -1.70%* -0.20% 0.57% -0.21% 0.56% 
 (0.83%) (0.83%) (0.93%) (0.82%) (0.93%) 
Q3 -1.36% -0.82% -0.60% -0.82% -0.59% 
 (0.85%) (0.80%) (0.85%) (0.80%) (0.84%) 
Q4 (High HL) Reference 
Age Cubic 
Splines 
      




  0.02% -0.63% 0.02% -0.62% 




  -0.01% -0.01% -0.02% -0.02% 
  (0.16%) (0.17%) (0.16%) (0.17%) 
Beds per 10K 
Residents 
  -0.02% -0.01% -0.02% -0.01% 
  (0.01%) (0.01%) (0.01%) (0.01%) 
Receives Low 
Income Subsidy 
  -1.79% -1.56% -1.80% -1.57% 
  (1.33%) (1.36%) (1.33%) (1.36%) 
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 -6.71%*** -6.74%*** -6.66%*** -6.69%*** 
  (1.63%) (1.65%) (1.63%) (1.65%) 
Partial Dual 
Eligible 
  -0.79% -0.81% -0.85% -0.86% 





Black  -6.41%*** -6.54%*** -6.41%*** -6.54%*** 
  (1.08%) (1.09%) (1.08%) (1.09%) 
Hispanic  4.26%* 3.93%* 4.25%* 3.94%* 
  (1.70%) (1.71%) (1.70%) (1.71%) 
Other  -0.38% -0.91% -0.27% -0.79% 
  (1.73%) (1.72%) (1.74%) (1.73%) 
Female 
  9.04%*** 8.93%*** 9.05%*** 8.94%*** 
  (0.59%) (0.60%) (0.59%) (0.60%) 
Diabetes 
  3.50%*** 3.42%*** 3.50%*** 3.43%*** 







1  0.64% 0.34% 0.64% 0.34% 
  (0.75%) (0.76%) (0.75%) (0.76%) 
2  1.53% 1.69% 1.53% 1.68% 
  (1.07%) (1.09%) (1.07%) (1.09%) 
3  -1.17% -0.90% -1.15% -0.89% 
  (1.52%) (1.54%) (1.52%) (1.54%) 
4+  -5.56%** -5.13%** -5.52%** -5.09%** 





2008  -0.62% -0.66% -0.90% -0.96% 
  (0.88%) (0.89%) (0.89%) (0.91%) 
2009  0.98% 0.56% 0.66% 0.20% 
  (0.99%) (1.01%) (1.03%) (1.04%) 
2010  1.65% 1.98% 1.33% 1.60% 
  (1.08%) (1.10%) (1.13%) (1.16%) 
2011  0.67% 0.34% 0.35% -0.01% 
  (1.11%) (1.12%) (1.15%) (1.17%) 
2012  -0.55% -0.61% -0.80% -0.88% 
  (1.09%) (1.10%) (1.11%) (1.13%) 
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2013  -3.67%*** -3.67%*** -3.97%*** -4.00%*** 
  -0.62% -0.66% -0.90% -0.96% 
State Fixed 
Effects 
  (0.95%) (0.97%) (0.98%) (1.00%) 
      
Rural 
   -1.90%*  -1.92%* 





Q2   -0.88%  -0.90% 
   (0.90%)  (0.89%) 
Q3   -0.71%  -0.73% 
   (1.02%)  (1.02%) 
Q4 (High 
Deprivation)   -0.90%  -0.86% 




    0.16%** 0.17%** 
    (0.05%) (0.06%) 
Percent 
Receiving PCI 
    -0.01% -0.01% 
       (0.04%) (0.04%) 
Observations  15,435 15,435 14,835 15,435 14,835 
Standard errors in parentheses. *** p<0.001, ** p<0.01, * p<0.05. 
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Low Health Literacy 
(Basic/Below Basic) 
  11.86%*** 3.33%* 3.36%* 2.94%* 2.90% 
 (1.29%) (1.45%) (1.51%) (1.44%) (1.50%) 
Age Cubic Splines 
      
      
Cardiologists per 10K 
Residents 
  -1.94% -1.34% -1.71% -1.21% 
  (1.01%) (1.07%) (1.00%) (1.06%) 
Primary Care Physicians per 
10K Residents 
  0.09% 0.12% 0.07% 0.10% 
  (0.21%) (0.21%) (0.20%) (0.21%) 
Beds per 10K Residents 
  0.03% 0.02% 0.02% 0.02% 
  (0.02%) (0.02%) (0.02%) (0.02%) 
Receives Low Income 
Subsidy 
  6.41%*** 5.91%*** 6.39%*** 5.88%*** 
  (1.60%) (1.63%) (1.59%) (1.63%) 
Full Dual Eligible 
  15.35%*** 15.99%*** 15.05%*** 15.71%*** 
  (1.83%) (1.87%) (1.83%) (1.86%) 
Partial Dual Eligible 
  4.05%* 4.91%* 3.79% 4.62%* 






 10.26%*** 10.49%*** 10.00%*** 10.20%*** 
 (1.64%) (1.68%) (1.64%) (1.67%) 
Hisp. 
 -6.66%*** -6.80%*** -6.57%*** -6.73%*** 
 (1.80%) (1.83%) (1.80%) (1.83%) 
Other 
 3.01% 3.48% 2.65% 3.12% 
 (2.16%) (2.19%) (2.16%) (2.19%) 
Female 
  -12.44%*** -12.10%*** -12.38%*** -12.05%*** 
  (0.77%) (0.78%) (0.77%) (0.78%) 
Diabetes 
  -4.76%*** -5.16%*** -4.78%*** -5.18%*** 
  (0.75%) (0.77%) (0.75%) (0.76%) 





 -2.07%* -1.84% -2.00%* -1.77% 
 (0.93%) (0.95%) (0.93%) (0.95%) 
2 
 1.65% 1.52% 1.69% 1.60% 
 (1.30%) (1.32%) (1.30%) (1.32%) 



















 (1.95%) (1.97%) (1.94%) (1.97%) 
4+ 
 14.26%*** 14.04%*** 14.20%*** 13.98%*** 






 -2.67%* -2.68%* -1.23% -1.21% 
 (1.11%) (1.13%) (1.12%) (1.14%) 
2009 
 -7.53%*** -7.10%*** -4.84%*** -4.38%*** 
 (1.23%) (1.25%) (1.27%) (1.29%) 
2010 
 -8.06%*** -8.01%*** -4.65%*** -4.55%** 
 (1.33%) (1.35%) (1.39%) (1.42%) 
2011 
 -5.75%*** -5.13%*** -2.53% -1.87% 
 (1.39%) (1.42%) (1.44%) (1.47%) 
2012 
 -0.88% -1.00% 1.41% 1.34% 
 (1.41%) (1.44%) (1.42%) (1.45%) 
2013 
 4.70%*** 4.91%*** 6.98%*** 7.21%*** 
 (1.30%) (1.33%) (1.32%) (1.35%) 
State Fixed Effects 
      
      
Rural 
   3.43%***  3.09%** 
   (1.03%)  (1.03%) 
ADI High Deprivation 
   0.10%  0.17% 
   (1.21%)  (1.20%) 
Percent Receiving CABG 
    -0.28%*** -0.28%*** 
    (0.07%) (0.07%) 
Percent Receiving PCI 
    -0.36%*** -0.36%*** 
       (0.04%) (0.05%) 
PCI 
Low Health Literacy 
(Basic/Below Basic) 
 -5.81%*** -0.36% -1.02% 0.01% -0.59% 
 (1.21%) (1.49%) (1.54%) (1.49%) (1.54%) 
Age Cubic Splines 
      
      
Cardiologists per 10K 
Residents 
  1.80% 1.85% 1.58% 1.71% 
  (1.01%) (1.08%) (1.01%) (1.08%) 
Primary Care Physicians per 
10K Residents 
  -0.07% -0.11% -0.03% -0.07% 
  (0.21%) (0.21%) (0.21%) (0.21%) 
Beds per 10K Residents 
  -0.01% -0.01% -0.01% -0.01% 
  (0.02%) (0.02%) (0.02%) (0.02%) 
Receives Low Income 
Subsidy 
  -4.68%** -4.48%** -4.65%** -4.44%** 
  (1.67%) (1.71%) (1.67%) (1.70%) 



















  (1.98%) (2.01%) (1.97%) (2.01%) 
Partial Dual Eligible 
  -3.30% -4.18% -2.99% -3.84% 
  (2.17%) (2.23%) (2.16%) (2.22%) 
Race 
White 
     
     
Black 
 -4.70%** -4.81%** -4.45%** -4.52%** 
 (1.62%) (1.66%) (1.62%) (1.66%) 
Hisp. 
 1.27% 1.87% 1.19% 1.78% 
 (1.99%) (2.02%) (1.98%) (2.02%) 
Other 
 -2.80% -2.82% -2.55% -2.56% 
 (2.21%) (2.23%) (2.21%) (2.23%) 
Female 
  3.39%*** 3.16%*** 3.32%*** 3.09%*** 
  (0.77%) (0.79%) (0.77%) (0.78%) 
Diabetes 
  1.28% 1.77%* 1.29% 1.78%* 
  (0.77%) (0.78%) (0.77%) (0.78%) 
Charlson Comorbidity Index 
0 
     
     
1 
 1.41% 1.48% 1.34% 1.42% 
 (0.96%) (0.98%) (0.96%) (0.98%) 
2 
 -3.15%* -3.21%* -3.20%* -3.28%* 
 (1.32%) (1.34%) (1.32%) (1.34%) 
3 
 -5.36%** -5.44%** -5.38%** -5.46%** 
 (1.93%) (1.96%) (1.93%) (1.95%) 
4+ 
 -8.65%*** -8.87%*** -8.63%*** -8.85%*** 
 (2.50%) (2.53%) (2.49%) (2.53%) 
Year 
2007 
     
     
2008 
 3.33%** 3.39%** 2.17% 2.22% 
 (1.13%) (1.15%) (1.16%) (1.18%) 
2009 
 6.58%*** 6.57%*** 4.20%** 4.21%** 
 (1.27%) (1.29%) (1.31%) (1.34%) 
2010 
 6.43%*** 6.04%*** 3.32%* 2.97%* 
 (1.37%) (1.40%) (1.43%) (1.45%) 
2011 
 5.17%*** 4.87%*** 2.24% 1.96% 
 (1.42%) (1.45%) (1.47%) (1.49%) 
2012 
 1.47% 1.64% -0.58% -0.43% 
 (1.41%) (1.44%) (1.43%) (1.46%) 
2013 
 -0.99% -1.18% -2.98%* -3.15%* 




      



















State Fixed Effects 
Rural 
      
   -1.74%  -1.38% 
ADI High Deprivation 
   (1.04%)  (1.04%) 
   1.11%  1.00% 
Percent Receiving CABG 
   (1.25%)  (1.24%) 
    0.12% 0.12% 
Percent Receiving PCI 
    (0.07%) (0.07%) 
    0.37%*** 0.37%*** 
     (0.05%) (0.05%) 
CABG 
Low Health Literacy 
(Basic/Below Basic)  -6.05%*** -2.98%** -2.34%* -2.95%** -2.31%* 
  (0.82%) (1.11%) (1.18%) (1.11%) (1.18%) 
Age Cubic Splines       
       
Cardiologists per 10K 
Residents   0.14% -0.51% 0.13% -0.50% 
   (0.80%) (0.87%) (0.80%) (0.87%) 
Primary Care Physicians per 
10K Residents   -0.03% -0.01% -0.03% -0.02% 
   (0.16%) (0.17%) (0.16%) (0.17%) 
Beds per 10K Residents   -0.02% -0.01% -0.02% -0.01% 
   (0.01%) (0.01%) (0.01%) (0.01%) 
Receives Low Income 
Subsidy   -1.73% -1.43% -1.74% -1.44% 
   (1.33%) (1.36%) (1.33%) (1.36%) 
Full Dual Eligible   -6.55%*** -6.62%*** -6.50%*** -6.57%*** 
   (1.63%) (1.65%) (1.62%) (1.65%) 
Partial Dual Eligible   -0.74% -0.73% -0.80% -0.77% 
   (1.73%) (1.77%) (1.73%) (1.77%) 
Race White  
Reference 
   
 Black  -5.55%*** -5.68%*** -5.55%*** -5.68%*** 
   (1.16%) (1.17%) (1.16%) (1.17%) 
 Hisp.  5.38%** 4.93%** 5.38%** 4.95%** 
   (1.77%) (1.78%) (1.77%) (1.78%) 
 Other  -0.21% -0.66% -0.10% -0.55% 
   (1.73%) (1.72%) (1.74%) (1.73%) 
Female   9.05%*** 8.94%*** 9.06%*** 8.96%*** 
   (0.59%) (0.60%) (0.59%) (0.60%) 
Diabetes   3.49%*** 3.40%*** 3.49%*** 3.41%*** 



















Charlson Comorbidity Index 0  
Reference 
   
 1  0.66% 0.36% 0.66% 0.35% 
   (0.75%) (0.76%) (0.75%) (0.76%) 
 2  1.51% 1.69% 1.51% 1.68% 
   (1.07%) (1.09%) (1.07%) (1.09%) 
 3  -1.11% -0.84% -1.10% -0.82% 
   (1.52%) (1.55%) (1.52%) (1.55%) 
 4+  -5.61%** -5.17%** -5.57%** -5.13%** 
   (1.78%) (1.83%) (1.79%) (1.83%) 
Year 2007  
Reference 
   
 2008  -0.66% -0.71% -0.94% -1.00% 
   (0.88%) (0.89%) (0.89%) (0.91%) 
 2009  0.95% 0.53% 0.64% 0.17% 
   (0.99%) (1.01%) (1.03%) (1.04%) 
 2010  1.63% 1.97% 1.33% 1.59% 
   (1.08%) (1.10%) (1.13%) (1.16%) 
 2011  0.59% 0.26% 0.29% -0.09% 
   (1.11%) (1.12%) (1.15%) (1.17%) 
 2012  -0.59% -0.64% -0.83% -0.90% 
   (1.09%) (1.11%) (1.11%) (1.13%) 
 2013  -3.71%*** -3.73%*** -4.00%*** -4.06%*** 
   (0.95%) (0.97%) (0.98%) (1.00%) 
State Fixed Effects       
       
Rural    -1.70%*  -1.71%* 
    (0.78%)  (0.78%) 
ADI High Deprivation    -1.21%  -1.17% 
    (0.95%)  (0.96%) 
Percent Receiving CABG     0.16%** 0.16%** 
     (0.05%) (0.06%) 
Percent Receiving PCI     -0.01% -0.01% 
        (0.04%) (0.04%) 
Observations  15,435 15,435 14,835 15,435 14,835 










Basic Controls, Rural, ADI, 
Treatment Patterns 
Variables  
ME (SE) ME (SE) 
Health Literacy 
Quartiles 
Q1 (Low HL) -5.37%*** -2.88% 
 (1.33%) (1.52%) 
 Q2 -3.70%*** -3.23%* 
  (1.07%) (1.52%) 
 Q3 -3.25%** -2.19% 
  (1.05%) (1.21%) 
 Q4 (High HL) Reference Reference 
Rural & ADI   ✓ 






Observations  15,435 14,835 
 Standard errors in parentheses. *** p<0.001, ** p<0.01, * p<0.05. 
Note: The marginal effects are with respect to probability of receiving a procedure (PCI or CABG). 
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Appendix Table 9. Marginal Effects for Logistic Regression of Treatment with Dichotomous 





Basic Controls, Rural, ADI, 
Treatment Patterns 
Variables 
ME (SE) ME (SE) 







ADI High Deprivation  
-0.40% 
 (1.22%) 




Observations 15,435 14,835 
Standard errors in parentheses. *** p<0.001, ** p<0.01, * p<0.05. 






APPENDIX 2. APPENDIX TABLES FOR CHAPTER 3 




The OPTION12 is a twelve-item scale that measures the degree to which clinicians involve patients in 
medical decision-making. The items are scored 0-4 as follows: no effort (0), minimal effort (1), some effort 
(2), skilled effort (3), and exemplary effort (4). The items are: 
1. The clinician draws attention to an identified problem as one that requires a decision-making 
process  
2. The clinician states that there is more than one way to deal with the identified problem (‘equipoise’) 
3. The clinician assesses the patient's preferred approach to receiving information to assist decision 
making 
4. The clinician lists ‘options’, which can include the choice of ‘no action’ 
5. The clinician explains the pros and cons of options to the patient (taking ‘no action’ is an option) 
6. The clinician explores the patient's expectations (or ideas) about how the problem(s) are to be 
managed 
7. The clinician explores the patient's concerns (fears) about how problem(s) are to be managed 
8. The clinician checks that the patient has understood the information 
9. The clinician offers the patient explicit opportunities to ask questions during the decision-making 
process 
10. The clinician elicits the patient's preferred level of involvement in decision making 
11. The clinician indicates the need for a decision-making (or deferring) stage 
12. The clinician indicates the need to review the decision (or deferment 
2. Patient 
Questions 
The total number of questions will be counted. In addition, each question will be categorized using the 
following criteria: 
1. Was the question clarifying previous information or bringing up a new topic? 
2. Was the question prompted by the clinician?  
3. Was the question open ended or closed?  
4. Was the question asked by a caregiver or family member? 
The total number of questions will be the main measure. Sensitivity analyses will be performed using each of 
the four sub-categories (new topic questions, unprompted questions, open ended questions, and whether 










The total number of times a patient expressed their preferences will be counted. In addition, each expression 
of preference will be categorized using the following criteria: 
1. Did the patient provide a rationale for their preference or did they just simply state their preference? 
2. Was the expression of preference prompted by the clinician? 
3. Was the patient pressured to express the preference by the clinician? For example, the clinician 
might ask a leading question about the patient’s preferences. 
The total number of expressions of preferences will be the main measure. Sensitivity analyses will be 
performed using each of the four sub-categories (expressions with rationale, unprompted expressions, 
unpressured expressions of preferences, and whether expressed by a caregiver or family member). 
4. Length of 
Discussion 








Appendix Table 11. Outcome Measures 
Measure Definition (From Patient Post Questionnaire) 
1. Treatment 
Selection 
ITEM 1: Which of the following best describes your current treatment plan for your stable coronary artery 
disease? 
• Medicines alone 
• Medicines plus stents 
• Other, please specify 
2. Patient 
Knowledge  
ITEM 2: Please respond to the following statements as best you can. [Responses: True, False, or Unsure] 
a. Getting a stent for stable coronary artery disease will reduce my risk of myocardial infarction or death 
when compared to medicines alone. 
b. At 1 month, there is no symptom improvement with medicines alone. 
c. At 1 month, more patients who got stents felt better when compared to patients on medicines alone 
d. At 1 year, patients on medicines alone feel about the same when compared to patients who got stents 
e. The added symptom relief with stents compared to medicines alone gets smaller over time 
f. There is a risk of having a myocardial infarction with the stent procedure itself 
g. Patients getting a stent can suffer more bleeding than patients on medicines alone. 
h. Stents eliminate symptoms of angina in all patients 
i. In 100 people who initially choose medicines alone, more than half will go on to need a stent during 
the next year 
j. In 100 people who initially choose a stent, 7 will need another procedure for stable coronary artery 
disease during the next year 




ITEM 2: Thinking about the conversation that you had with your clinician today about stents plus medicines versus 
medicines alone for stable coronary artery disease, please mark the response that best describes your 
agreement with the following statements.  
[Responses Are: 1) Strongly Agree, 2) Agree, 3) Neither Agree Nor Disagree, 4) Disagree, and 5) Strongly 
Disagree] 
a. I know which options are available to me 
b. I know the benefits of each option 
c. I know the risks and side effects of each  
Each of the questions will be assessed independently since they relate to different aspects of treatment and the 






Measure Definition (From Patient Post Questionnaire) 
4. Patient 
Satisfaction 
ITEM 3: Thinking about the conversation that you had with your clinician today about stents plus medicines 
versus medicines alone for stable coronary artery disease, please mark the response that best describes your 
agreement with the following statements.  
[Responses Are: 1) Strongly Agree, 2) Agree, 3) Neither Agree Nor Disagree, 4) Disagree, and 5) Strongly 
Disagree] 
a. I am clear about which benefits matter most to me 
b. I am clear about which risks and side effects matter most to me  
c. I have enough support from others to make a choice  
d. I am choosing without pressure from others 
e. I have enough advice to make a choice 
f. I am clear about the best choice for me 
g. I feel sure about what to choose 
h. This decision is easy for me to make 
i. I feel I have made an informed choice 
j. My decision shows what is important to me 
k. I expect to stick with my decision 
l. I am satisfied with my decision 
ITEM 5: How would you describe the clarity of information about stents plus medicines versus medicines 
alone for stable coronary artery disease given during this visit? [Responses Are: 1-7 from 1 “Too Little 
Information” to 7 “Too much Information”] 
An overall patient satisfaction score will be created by summing the number of elements in Item 3 for which 
the patient responded “Strongly Agree” or “Agree.” Item 5 will be analyzed separately from the total patient 







Appendix Table 12. Health Literacy Measure  
Measure Definition (From Patient Pre Questionnaire) 
Health Literacy ITEMS 8: How often do you have someone (like a family member, friend, hospital/clinic worker, or caregiver) 
help you read hospital materials? 
1) All of the time 
2) Most of the time 
3) Some of the time 
4) A little of the time  
5) None of the Time 
ITEM 9: How often do you have problems learning about your medical condition because of difficulty 
understanding written information? 
[Same responses as above] 
ITEM 10: How confident are you filling out healthcare forms by yourself? 
1) Extremely 
2) Quite a bit 
3) Somewhat 
4) A little bit  
5) Not at all  
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APPENDIX 3. APPENDIX TABLES FOR CHAPTER 4 
Appendix Table 13. Diagnostic Algorithms for Identifying Stable Angina Pectoris  
Algorithm Diagnostic Criteria Medication Criteria 
1 • 2 claims with diagnoses for stable 
angina pectoris  
• 2 claims for nitrates for medical therapy  
• No claims for nitrates required for PCI or 
CABG 
2 • 2 claims with diagnoses for 
coronary artery disease 
• 2 claims with diagnoses for chest 
pain 
• 2 claims for nitrates for medical therapy  
• No claims for nitrates required for PCI or 
CABG 
Adapted from Kempf et al. 2011. Note that medication use was not required for patients receiving PCI or 
CABG because receiving a procedure was considered sufficient evidence that the patient had stable 
angina pectoris.  
 
Appendix Table 14. International Classification of Diseases, Ninth Revision  
Diagnosis  ICD-9 Codes 
Stable angina pectoris 413.0, 413.1, 413.9 
Coronary artery disease 411.0, 411.1, 411.8, 411.81, 411.89, 414.00, 414.01, 
414.02, 414.03, 414.04, 414.05, 414.06, 414.07, 414.10, 
414.11, 414.12, 414.19, 414.2, 414.3, 414.8, 414.9, 
429.2, 429.6, 429.71, 429.79, 996.03, V45.81, V45.82 
Chest pain 786.51, 785.52, 786.59 
Myocardial infarction 410.0, 410.1, 410.2, 410.3, 410.4, 410.5, 410.6, 410.7, 
410.8, 410.00, 410.01, 410.02, 410.10, 410.11, 410.12, 
410.20, 410.21, 410.22, 410.30, 410.31, 410.32, 410.40, 
410.41, 410.42, 410.50, 410.51, 410.52, 410.60, 410.61, 
410.62, 410.70, 410.71, 410.72, 410.80, 410.81, 410.82, 
410.90, 410.91, 410.92, 412" 
 
Unstable angina pectoris 411.1 
Diabetes 249.01, 249.10, 249.11, 249.20, 249.21, 249.30, 249.31, 
249.40, 249.41, 249.50, 249.51, 249.60, 249.61, 249.70, 
249.71, 249.80, 249.81, 249.90, 249.91, 250.00, 250.01, 
250.02, 250.03, 250.10, 250.11, 250.12, 250.13, 250.21, 
250.22, 250.23, 250.30, 250.31, 250.32, 250.33, 250.40, 
250.41, 250.42, 250.43, 250.50, 250.51, 250.52, 250.53, 
250.60, 250.61, 250.62, 250.63, 250.71, 250.72, 250.73, 




Appendix Table 15. Procedural Codes  
Procedure Code Type Codes 
PCI CPT (pre 2013) 92980, 92981, 92982, 92983, 92984, 
92995, 92996 
CPT (post 2013) 92920, 92921, 92924, 92925, 92928, 
92929, 92933, 92934, 92937, 92938 
ICD-9 Procedure 00.66, 36.06, 36.01, 36.02, 36.05, 
36.09 
DRG (pre 2008) 518, 555, 556, 557, 558 
DRG (post 2008) 246, 247, 248, 249, 250, 251 
CABG CPT 33510, 33511, 33512, 33513, 33514, 
33516, 33517, 33518, 33519, 33520, 
33521, 33522, 33523, 33530, 33533, 
33534, 33535, 33536 
ICD-9 Procedure 36.1, 36.10, 36.11, 36.12, 36.13, 
36.14, 36.15, 36.16, 36.17, 36.19 
DRG (pre 2008) 106, 547, 548, 549, 550 
 DRG (post 2008) 231, 232, 233, 234, 235, 236 
Note: CABG stands for coronary artery bypass graft surgery, CPT stands for current procedural 






Appendix Table 16. Standardized Differences Before and After IPTW for Binary Health Literacy 
  Unweighted Weighted 











Basic 6.4% 11.9% 0.18 8.6% 10.8% 0.069 
Age  73.4 76.9 0.46 75.0 75.9 0.12 
Cardiologists per 
10K  0.7 0.7 0.04 0.6 0.7 0.05 
PCPs per 10K  7.0 7.2 0.05 7.0 7.1 0.05 
Beds per 10K  33.3 34.2 0.03 32.2 34.0 0.07 
Low Income 
Subsidy  0.2 0.3 0.36 25.4% 30.1% 0.10 
Dual Eligible  9.2% 22.3% 0.34 14.4% 18.7% 0.11 
Partial Dual Eligible  4.8% 7.1% 0.10 5.6% 6.5% 0.04 
RTI Race Black 3.6% 9.2% 0.21 5.7% 8.0% 0.08 
RTI Race Hispanic 5.6% 5.5% 0.01 5.4% 5.3% 0.00 
RTI Race Other 3.8% 4.0% 0.01 4.2% 3.8% 0.02 
Female  67.9% 35.6% 0.66 47.5% 42.4% 0.10 
Diabetes  49.0% 38.1% 0.22 42.3% 40.6% 0.04 
Charlson 
Comorbidity Index One 19.2% 20.0% 0.02 19.4% 19.6% 0.01 
 Two 9.3% 9.2% 0.00 8.7% 8.9% 0.01 
 Three 3.0% 4.3% 0.07 3.0% 3.8% 0.04 
 Four 1.0% 2.5% 0.10 1.0% 2.1% 0.08 
Year 2008 17.8% 17.9% 0.00 17.8% 17.8% 0.00 
 2009 14.7% 12.2% 0.07 14.1% 12.8% 0.04 
 2010 11.7% 9.6% 0.07 11.8% 10.2% 0.05 
 2011 10.8% 9.0% 0.06 9.6% 9.3% 0.01 
 2012 9.5% 9.3% 0.01 8.9% 9.5% 0.02 
 2013 11.2% 13.5% 0.07 12.0% 13.1% 0.03 
ADI Category 
High 
Deprivation 11.3% 13.9% 0.08 11.8% 13.4% 0.05 
Rural  25.7% 25.4% 0.01 26.0% 25.8% 0.00 
  CABG PCI 
Std. 





Basic 6.4% 8.9% 0.08 8.6% 10.1% 0.05 
Age  73.4 73.8 0.06 75.0 75.3 0.04 
Cardiologists per 
10K  0.7 0.7 0.03 0.6 0.7 0.05 
PCPs per 10K  7.0 7.1 0.01 7.0 7.1 0.03 
Beds per 10K  33.3 34.1 0.03 32.2 33.6 0.05 
Low Income 
Subsidy  18.4% 21.2% 0.06 25.4% 27.9% 0.05 
Dual Eligible  9.2% 11.1% 0.05 14.4% 16.6% 0.06 
Partial Dual Eligible  4.8% 5.6% 0.03 5.6% 6.1% 0.02 
RTI Race Black 3.6% 5.8% 0.08 5.7% 7.1% 0.06 
RTI Race Hispanic 5.6% 5.0% 0.03 5.4% 5.7% 0.01 
RTI Race Other 3.8% 2.8% 0.06 4.2% 3.3% 0.05 
Female  67.9% 53.6% 0.29 47.5% 44.9% 0.05 
Diabetes  49.0% 45.1% 0.08 42.3% 42.7% 0.01 
Charlson 
Comorbidity Index One 19.2% 19.5% 0.01 19.4% 20.3% 0.02 
 Two 9.3% 8.5% 0.03 8.7% 8.9% 0.01 
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 Three 3.0% 2.8% 0.01 3.0% 3.2% 0.01 
 Four 1.0% 1.4% 0.03 1.0% 1.7% 0.05 
Year 2008 17.8% 18.1% 0.01 17.8% 18.4% 0.02 
 2009 14.7% 14.6% 0.00 14.1% 13.5% 0.02 
 2010 11.7% 12.2% 0.02 11.8% 10.7% 0.04 
 2011 10.8% 10.4% 0.02 9.6% 9.8% 0.01 
 2012 9.5% 9.3% 0.01 8.9% 9.4% 0.02 
 2013 11.2% 12.2% 0.03 12.0% 12.5% 0.01 
ADI Category 
High 
Deprivation 11.3% 13.3% 0.06 11.8% 13.7% 0.06 












Basic 11.9% 8.9% 0.09 10.8% 10.1% 0.02 
Age  76.9 73.8 0.40 75.9 75.3 0.08 
Cardiologists per 
10K  0.7 0.7 0.01 0.7 0.7 0.00 
PCPs per 10K  7.2 7.1 0.04 7.1 7.1 0.01 
Beds per 10K  34.2 34.1 0.00 34.0 33.6 0.01 
Low Income 
Subsidy  0.3 0.2 0.30 0.3 0.3 0.05 
Dual Eligible  0.2 0.1 0.29 0.2 0.2 0.06 
Partial Dual Eligible  0.1 0.1 0.06 0.1 0.1 0.02 
RTI Race Black 9.2% 5.8% 0.13 8.0% 7.1% 0.03 
RTI Race Hispanic 5.5% 5.0% 0.02 5.3% 5.7% 0.02 
RTI Race Other 4.0% 2.8% 0.06 3.8% 3.3% 0.02 
Female  35.6% 53.6% 0.37 42.4% 44.9% 0.05 
Diabetes  38.1% 45.1% 0.14 40.6% 42.7% 0.04 
Charlson 
Comorbidity Index One 20.0% 19.5% 0.01 19.6% 20.3% 0.02 
 Two 9.2% 8.5% 0.02 8.9% 8.9% 0.00 
 Three 4.3% 2.8% 0.08 3.8% 3.2% 0.03 
 Four 2.5% 1.4% 0.08 2.1% 1.7% 0.03 
Year 2008 17.9% 18.1% 0.01 17.8% 18.4% 0.01 
 2009 12.2% 14.6% 0.07 12.8% 13.5% 0.02 
 2010 9.6% 12.2% 0.08 10.2% 10.7% 0.02 
 2011 9.0% 10.4% 0.05 9.3% 9.8% 0.02 
 2012 9.3% 9.3% 0.00 9.5% 9.4% 0.00 
 2013 13.5% 12.2% 0.04 13.1% 12.5% 0.02 
ADI Category 
High 
Deprivation 13.9% 13.3% 0.02 13.4% 13.7% 0.01 




Appendix Table 17. Descriptive Statistics by Health Literacy Category 









Adherent (PDC>80%) First Six 
Months Following Diagnosis 
Adherent  1,409 (74.6%)  12,379 (79.2%)  13,788 (78.7%) 
Non-Adherent  481 (25.4%)  3,247 (20.8%)  3,728 (21.3%) 
Adherent (PDC>80%) Second Six 
Months Following Diagnosis 
Adherent  1,149 (60.8%)  10,582 (67.7%)  11,731 (67.0%) 
Non-Adherent  741 (39.2%)  5,044 (32.3%)  5,785 (33.0%) 
First Treatment Received 
Medication 
Only  1,428 (75.6%)  10,474 (67.0%)  11,902 (67.9%) 
PCI  351 (18.6%)  3,573 (22.9%)  3,924 (22.4%) 
CABG  111 (5.9%)  1,579 (10.1%)  1,690 (9.6%) 
Sex 
Male  1,227 (64.9%)  8,798 (56.3%)  10,025 (57.2%) 
Female  663 (35.1%)  6,828 (43.7%)  7,491 (42.8%) 
Age 
65-70  579 (30.6%)  4,060 (26.0%)  4,639 (26.5%) 
70-75  424 (22.4%)  3,431 (22.0%)  3,855 (22.0%) 
75-80  356 (18.8%)  3,002 (19.2%)  3,358 (19.2%) 
80+  531 (28.1%)  5,133 (32.8%)  5,664 (32.3%) 
RTI Race 
White  559 (29.6%)  13,960 (89.3%)  14,519 (82.9%) 
Black  745 (39.4%)  635 (4.1%)  1,380 (7.9%) 
Hispanic  472 (25.0%)  483 (3.1%)  955 (5.5%) 
Other  114 (6.0%)  548 (3.5%)  662 (3.8%) 
Diabetes 
No  907 (48.0%)  9,475 (60.6%)  10,382 (59.3%) 
Yes  983 (52.0%)  6,151 (39.4%)  7,134 (40.7%) 
Charlson Comorbidity Index 
0  1,102 (58.3%)  10,316 (66.0%)  11,418 (65.2%) 
1  403 (21.3%)  3,072 (19.7%)  3,475 (19.8%) 
2  215 (11.4%)  1,373 (8.8%)  1,588 (9.1%) 
3  117 (6.2%)  551 (3.5%)  668 (3.8%) 
4+  53 (2.8%)  314 (2.0%)  367 (2.1%) 
Year 
2007  618 (32.7%)  4,085 (26.1%)  4,703 (26.8%) 
2008  354 (18.7%)  2,809 (18.0%)  3,163 (18.1%) 
2009  237 (12.5%)  2,049 (13.1%)  2,286 (13.1%) 
2010  210 (11.1%)  1,593 (10.2%)  1,803 (10.3%) 
2011  159 (8.4%)  1,504 (9.6%)  1,663 (9.5%) 
2012  134 (7.1%)  1,495 (9.6%)  1,629 (9.3%) 
2013  178 (9.4%)  2,091 (13.4%)  2,269 (13.0%) 
Area Deprivation Index Category 
Low 
Deprivation  1,028 (54.4%)  14,020 (89.7%)  15,048 (85.9%) 
High 
Deprivation  862 (45.6%)  1,606 (10.3%)  2,468 (14.1%) 
Rural Status 
Urban  1,597 (84.5%)  11,601 (74.2%)  13,198 (75.3%) 
Rural  293 (15.5%)  4,025 (25.8%)  4,318 (24.7%) 
Continuous Variables   Mean (SD) Mean (SD) Mean (SD) 
Cardiologists per 10K     0.79 (0.56)  0.67 (0.60)  0.68 (0.60) 
PCPs per 10K     7.06 (2.49)  7.21 (2.90)  7.19 (2.86) 
Beds per 10K     38.09 (26.30)  33.53 (26.78)  34.02 (26.77) 
Full Dual Eligible*    45.0% (48.6%)  15.4% (35.3%)  18.6% (38.1%) 
Partial Dual Eligible*    10.8% (29.6%)  5.9% (22.5%)  6.4% (23.4%) 
Receives Low Income Subsidy*    63.9% (47.6%)  25.8% (43.4%)  29.9% (45.4%) 
Area-Level Measure of Pct. 
Receiving PCI    21.5% (6.6%)  22.1% (7.1%)  22.1% (7.1%) 
Area-Level Measure of Pct. 













ADI & Rural  
IPTW with Basic 
Controls  
IPTW with ADI 
& Rural  
2SRI with Basic 
Controls 
2SRI with ADI 
& Rural 
  ME (SE) ME (SE) ME (SE) ME (SE) ME (SE) ME (SE) 
Health Literacy 
Quartile 
Q1 -2.61%** (1%) -3.07%** (1.11%) -3.21%** (1.23%) -4.55%** (1.65%) -2.34%* (1.05%) -2.78%* (1.13%) 
Q2 -0.7% (0.81%) -1.22% (0.89%) -0.5% (1.01%) -1.36% (1.35%) -0.6% (0.87%) -1.17% (0.95%) 
Q3 -0.41% (0.81%) -0.9% (0.85%) 0.56% (1%) -0.19% (1.29%) -0.3% (0.83%) -0.82% (0.9%) 
Q4 Reference 
Med. Only  Reference 
CABG  -2.61%** (1%) -3.07%** (1.11%) -3.21%** (1.23%) -4.55%** (1.65%) 18.55%* (8.12%) 17.99%* (8.91%) 
PCI  -0.7% (0.81%) -1.22% (0.89%) -0.5% (1.01%) -1.36% (1.35%) -3.06% (8.95%) -2.46% (9.06%) 
Cardiologists per 10K  0.0004 (0.0071) 0.0089 (0.0076) -0.0024 (0.0082) 0.0035 (0.011) 0.0004 (0.0074) 0.0089 (0.0077) 
PCPs per 10K  0.0019 (0.0015) 0.0018 (0.0015) 0.0008 (0.0017) 0.0013 (0.0022) 0.0024 (0.0016) 0.0022 (0.0017) 
Beds per 10K  -0.0001 (0.0001) -0.0002 (0.0001) -0.0001 (0.0001) -0.0002 (0.0002) -0.0001 (0.0001) -0.0002 (0.0001) 
Low Income Subsidy  2.64% (1.24%) 0.32% (1.27%) 0.54% (1.54%) 0.76% (1.97%) 0.66% (1.29%) 0.73% (1.33%) 
Dual Eligible  -0.69% (1.38%) -0.8% (1.41%) -1.8% (1.85%) -2.43% (2.34%) 0.27% (1.47%) 0.13% (1.52%) 
Partial Dual Eligible  -1.15% (1.58%) -1.36% (1.62%) -0.49% (1.95%) -0.73% (2.56%) -0.78% (1.62%) -1.06% (1.57%) 
Race 
White Reference 
Black -4.23%** (1.22%) -3.77%** (1.25%) -0.98% (1.61%) -0.44% (1.9%) -3.31%** (1.27%) -2.85%* (1.4%) 
Hispanic -8.88%*** (1.48%) -8.16%*** (1.51%) -5.91%** (1.7%) -5.39%* (2.16%) 
-9.44%*** 
(1.51%) -8.7%*** (1.62%) 
Other -3.08% (1.63%) -2.34% (1.66%) -3.49% (2.38%) -1.66% (2.99%) -3.48%* (1.75%) -2.64% (1.63%) 









1 -1.06% (0.74%) -1.21% (0.76%) -0.03% (0.92%) 0.1% (1.12%) -1.26% (0.77%) -1.36% (0.8%) 
2 0.63% (1%) 0.39% (1.02%) -1.57% (1.33%) -2.05% (1.7%) 0.28% (1.07%) 0.01% (1.11%) 
3 2.58% (1.42%) 2.2% (1.45%) 1.06% (1.92%) 0.81% (2.11%) 2.61% (1.4%) 2.2% (1.45%) 
4+ 0.51% (1.98%) 0.15% (2.02%) 1% (2.6%) 0.01% (3.43%) 1.28% (1.99%) 0.85% (1.89%) 
Year 
2007 Reference 
2008 -0.72% (0.89%) -0.44% (0.9%) 0.57% (1.08%) 0.51% (1.35%) -0.81% (0.97%) -0.56% (0.95%) 
2009 0.44% (0.98%) 0.38% (1%) 2.14% (1.24%) 1.38% (1.58%) 0.12% (1.04%) 0.11% (1.08%) 
2010 -0.01% (1.06%) 0.57% (1.08%) -0.44% (1.42%) -0.26% (1.72%) -0.26% (1.21%) 0.21% (1.24%) 
2011 1.44% (1.08%) 1.66% (1.1%) 2.34% (1.29%) 1.99% (1.59%) 1.25% (1.2%) 1.51% (1.09%) 
2012 5.34%*** (1.05%) 4.97%*** (1.08%) 4.98%*** (1.33%) 4.08%* (1.58%) 5.43%*** (1.12%) 5.03%*** (1.13%) 
2013 6.12%*** (0.95%) 6.44%*** (0.97%) 6.94%*** (1.15%) 6.98%*** (1.43%) 6.63%*** (0.96%) 6.92%*** (0.98%) 












ADI & Rural  
IPTW with Basic 
Controls  
IPTW with ADI 
& Rural  
2SRI with Basic 
Controls 
2SRI with ADI 
& Rural 
  ME (SE) ME (SE) ME (SE) ME (SE) ME (SE) ME (SE) 
ADI Quartiles 
Q1 Reference 
Q2  1.22% (0.85%)  3.62%** (1.3%)  1.45% (0.91%) 
Q3  1.47% (0.94%)  2.54% (1.45%)  1.52% (0.97%) 
Q4  0.17% (1.07%)  2.55% (1.62%)  0.14% (1.15%) 
Period 
 
11.76%*** (0.32%) 11.75%*** (0.32%) 12.17%*** (0.71%) 12.2%*** (0.53%) 11.76%*** (0.3%) 11.75%*** 
(0.33%) 
Note: ME stands for marginal effect, SE stands for standard error, IPTW stands for inverse probability of treatment weighting, 2SRI stands for two-stage residual inclusion, CABG 
stands for coronary artery bypass grafting, PCI stands for percutaneous coronary 
 132 
Appendix Table 19. Marginal Effects for Alternative Residual Specifications with Binary Health 
Literacy 
 Raw Residuals 
Standardized 
Residuals Deviance Residuals 
 ME SE ME SE ME SE 
Low HL -0.89% 1.33% -1.49% 1.27% -1.07% 1.31% 
CABG 20.07%** 7.98% -1.29% 2.94% 14.07% 9.07% 
PCI -5.05% 9.11% 0.52% 3.94% -3.33% 11.05% 
 
 
Appendix Table 20. Marginal Effects for Alternative Residual Specifications with Quartile Health 
Literacy 
 Raw Residuals 
Standardized 
Residuals Deviance Residuals 
 ME SE ME SE ME SE 
Q1 2.78%* 1.27% -3.01%* 1.17% -2.88%* 1.24% 
Q2 -1.17% 0.86% -1.16% 0.80% -1.19% 0.81% 
Q3 -0.82% -0.82% -0.88% 0.74% -0.85% 0.78% 
Q4 Reference  Reference  Reference  
CABG 17.99% -3.01% -1.45% 3.00% 12.52% 9.96% 





APPENDIX 4. APPENDIX FIGURES FOR CHAPTER 5 





Appendix Figure 2. Days After Initial Diagnosis Until PCI Procedure 
 
